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I. INTRODUCTION 
A. Introduction 
The Immunology of reproduction Is the study of why the 
maternal Immune system tolerates the fetal allograft. In 
an outbred population, such as humans, the parents possess 
four distinct major histocompatibility complex (MHO 
haplotypes (e.g., A/B for father and C/D for mother). The 
offspring express one of four distinct haplotypes: A/C, 
A/D, B/C, or B/D. Each parent has one haplotype which is 
foreign to each child, but more importantly, each child 
expresses one haplotype which Is foreign to the mother 
(20,58). 
In mice, MHC molecules are known to be on the surface 
of prelmplantatIon (30-35,45-49) and post-implantation 
embryos (50). Paternal MHC antigens comprise 20 to 50% of 
the MHC molecules on post-Implantation embryos (39) and are 
known to be present on prelmplantation embryos (Warner et. 
al., 1987, ISU, unpublished observations). 
Two Important questions about embryonic development 
need to be addressed. First, can the embryo's MHC and 
other antigens be recognized as foreign by the Immune cells 
of the maternal system? And secondly, if these antigens 
are recognized, what protects the prelmplantatIon embryo 
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from destruction by the maternal Immune system? 
B. Specific Goals 
An interesting question is whether cytotoxic immune 
cells will recognize preimplantation embryos as foreign 
tissue. The cytotoxic immune cells used in this study, 
cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, 
and lymphokine activated killer (LAK) cells had their 
phenotypic and cytolytic characteristics determined. The 
cytotoxic immune cells were used in an assay, MELIA (mixed 
embryo leukocyte Interaction assay) to test the ability of 
the cells to kill blastocyst stage embryos. The lysis of 
the blastocysts was determined by the inhibition of 
retention of blastocoels by the blastocysts and/or by the 
Inhibition of Incorporation of tritiated thymidine (^H-TdR) 
Into embryonic DMA. Blastocysts which either possessed or 
lacked their zonae pellucidae were tested to determine 
whether the zona pelluclda plays an immunoprotectIve role 
in preimplantatIon development. 
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II. LITERATURE REVIEW 
A. Murine Major Histocompatibility Complex 
One group of proteins involved in cellular 
communication is from the major histocompatibility complex 
(MHC). MHC molecules have been implicated in the following 
forms of cellular interaction: modulation of cell 
metabolism, cell positioning, cellular differentiation, 
levels of drug and hormone binding, levels of cAMP 
response, control of immune response (I), and rate of 
preimplantation embryo development (2-4). Even though the 
other interactions are important, the major function of the 
MHC involves the immune response. 
Three classes of glycoproteins are encoded within the 
H-2 complex on chromosome 17 (5-10). The class I and II 
proteins are important In the regulation of the immune 
response, while the third set of proteins, the S or class 
III proteins, are serum complement components. The order 
of the loci within the H-2 complex with H-2K proximal to 
the centromere is as follows: 
H-2K -- I — S -- H-2D,L Qa-2,3 --//-- TI a 
The total size of the complex is approximately 4000 kb 
(kilobases) or about 2 cM (centimorgan) (10). 
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1. Function and structure of class 1 genes and proteins 
There are four regions within the H-2 complex which 
encode for class I molecules: H-2K. H-2D,L. Qa-2.3. and 
T1 a (5-10). Class 1 molecules are the classical 
transplantation antigens found on all cells. 
The Kf D, and L molecules are highly polymorphic, are 
ubiquitously expressed, and are required for the Initial 
activation of T cells (13) and for the recognition of 
target cells by cytotoxic T lymphocytes (CTLs) (14). The T 
cell receptor for CTLs only recognizes virus-associated 
proteins when binding to either the public or private 
portions of these class I molecules (15). The Qa-2,3 and 
Tla proteins are not as polymorphic as K, D, and L 
molecules. These proteins are expressed on a limited 
number of cells, and they have no known function (5-10). 
The class I protein Is composed of a 45,000 dalton 
(45-kD) protein from the H-2 complex which Is noncovalently 
associated at with a 12-kD polypeptide from chromosome 2, 
the Gg'^lcroglobulln (B2I'"). The heavy chain Is composed of 
three extracellular domains (a^, , a^), a transmembrane 
segment, and a small cytoplasmic sequence (5-10). 
The structure of the exon-lntron class I genes 
corresponds fairly well with the structure of the class 1 
proteins (5-10). The genes are comprised of an exon for 
the leader sequence (L), exons for each extracellular 
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domain (a^, , a^), a single transmembrane exon (TM), and 
three exons for the cytoplasmic segment (cyt) (5-10). QIO, 
the first described soluble class I protein, lacks the 
transmembrane and cytoplasmic portions of the protein due 
to multiple substitutions within its class I exons (11,12). 
The number of class I genes varies depending on the 
strain of mouse (7-9). The H-2 complex of C57BL/10 (H-2^^ 
and BALB/c (H-2'^) mice have been characterized fairly well. 
Both strains contain two genes within the H-2K region that 
have a head-to-tail configuration. The H-2^ haplotype 
contains only one gene in the H-2D region, while H-2'^ 
contains 5 genes within the H-2D/H-2L region. The majority 
of the genes for both haplotypes reside within the Oa-2,3 
and Tla regions. The H-2^ haplotype contains 10 genes in 
the Oa-2.3 region and 13 genes in the Tla region. The H-2^ 
haplotype contains 7 genes and one pseudogene in the Oa-2,3 
region and 18 genes in the TIa region. Overall, the H-2^ 
haplotype has 26 genes and the H-2^ haplotype has 32 class 
I genes (7-9). 
2. Function and structure of class 11 genes and proteins 
The genes for the class II antigens are encoded in two 
loci within the H-2 complex, 1-A and 1-E. which map between 
H-2K and H-2D.L. Class II genes encode the la molecules 
which are responsible for the control of.the immune 
6 
response. 
The la molecules are highly polymorphic, are expressed 
primarily on the surface of B cells, macrophages and 
certain epithelial cells, and direct recognition of foreign 
antigen by helper T cells. The helper T cell recognition 
of foreign antigen In conjunction with the class II 
molecule Is Important for the generation of CTL and for the 
production of antibody by B cells (5-7,9,10,13). 
The I-A region contains the and genes, 
and the 1-E region contains the gene. The class II 
protein, the la molecule. Is a heterodlmer composed of a 
35-kD a chain noncova1entI y associated with a 29-kD B 
chain. The a and B chain have two extracellular domains, a 
transmembrane segment, and a small cytoplasmic sequence (5-
7,9,10). 
The structure of the exon-lntron class II genes 
corresponds fairly well with the structure of the class II 
proteins (5-7,9,10). The genes contain an exon for the 
leader sequence (L), exons for each extracellular domain 
(al and o2 or B1 and B2), a single transmembrane exon (TM), 
and two exons for the cytoplasmic fragment (cyt) (5-7,9, 
10). 
Eight genes are located within the la region. Besides 
the previously mentioned genes (^j, A^, Egi» and E^) two 
more genes, and Egg, may be functional. The ^ 3 and 
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Egg genes are B-related sequences; ^ 3 Is s pseudogene, and 
^3 maps within the class III region (5-7,9,10). 
3. Definitions; haolotvpes and congenlc mice 
The high degree of polymorphism within the H-2 complex 
has allowed the serological differentiation of strains of 
mice. Eleven Independent haplold types or haplotypes are 
found within the Inbred strains: b, d, f, J, k, p, q, r, 
s, u, and v (16). These haplotypes are differentiated by 
private serological (16) and cellular (17) markers which 
correspond to the variable portion of the H-2 antigens. 
The haplotypes share public serological markers which 
correspond to the constant portion of the H-2 antigens. 
In an attempt to understand Individual loci within the 
genome of the mouse, George D. Snell decided to separate 
these loci. Through an elaborate series of matlngs, he 
developed congenlc mice, whose genome differs at only one 
locus (10). For example, the haplotypes for C57BL/10 (810) 
and DBA/2 (02) mice are H-2'^ and H-2^. respectively. The 
H-2 congenlc strain 810.02 (H-2'^) contains the background 
genes from the C57BL/10 strain and the H-2 genes from the 
DBA/2 strain. 
8 
B. Early Embryonic Development 
1. Morphology of the preimplantation stages of mouse 
embryonic development 
For the 2-3 week period before ovulation, the mouse 
oocyte grows from 12 to 85 wm in diameter (18). After 
ovulation, the oocyte is swept by cilia into the ampulla of 
the oviduct where fertilization occurs. 
A sperm can fertilize an egg only after passing 
through the cumulus cells, the corona radiata, and the zona 
pellucida. The cumulus cells are a mass of loosely packed 
cells derived from the granulosa cells of the follicle. 
The corona radiata consists of follicular cells which are 
attached to the zona pellucida (19,20,21). The zona 
pellucida is a relatively thick (17 um) extracellular coat 
which is produced by the oocyte and constructed of three 
acidic glycoproteins: ZPl (200 kd), ZP2 (120 kd), and ZP3 
(83 kd) (18,22,23). The sperm receptor activity of ZP3 is 
dependent only on the 0-1 Inked carbohydrate components of 
ZP3 (24,25), while the acrosome reaction-inducing activity 
(fusion of sperm's and egg's membranes) is dependent on the 
polypeptide portion of ZP3 as well (26). During the fusion 
of the two cells' membranes, ZP2 undergoes structural 
rearrangement to prevent polyspermy (27). The third 
protein of the zona pellucida, ZPl, is a structural protein 
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that helps prevent the embryo from sticking to the oviduct 
( 2 8 ) .  
While being transported down the oviduct after 
fertilization, each cell, or blastomere, of the two cell 
embryo undergoes a series of divisions during which the 
total size of the embryo remains approximately the same 
(19,20,21). The rate of this cleavage Is very slow, as it 
takes almost 3 days for the embryo to divide 5 times. At 
about the 4- to 8-cell stage, the embryo undergoes a change 
In morphology: the cells compact to yield a morula. A 
second morphological change occurs when the morula changes 
from a morula to a blastocyst. 
The blastocyst contains two types of cells: an outer 
rim of trophectoderm cells which surrounds a blastocoelic 
cavity that contains blastocoelic fluid, and a cluster of 
cells called the Inner cell mass (ICH), which Is 
eccentrically placed against one pole of the cavity. The 
trophectoderm cells constitute the extra embryonic cells 
that eventually will become the placenta, while the I CM 
cells will become the embryo proper (19,20,21). At this 
time the embryo enters the uterus where It hatches from 
zona pelluclda by using a trypsin-like proteinase (18). 
After the hatching process, the embryo Is ready to Interact 
with the uterine endometrium and Initiate Implantation 
(19,20,21). 
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2. Expression of H-2 mRNA within prelmplantatlon embryos 
The large volume of oocyte cytoplasm contains the 
essential materials for the progress of cleavage, perhaps 
to the 8-cel1 stage. Even though all the classes of RNA 
are synthesized by the 2-cell embryo, RNA synthesis 
Intensifies from the 8-cel1 stage onwards, resulting In a 
6-fold Increase in total RNA content between the 2-cell 
stage and early blastocyst stage. Approximately half of 
the maternal RNA is eliminated by the 2 cell stage, and at 
most 30% remains at the early blastocyst stage; almost a 
complete shift from maternal to embryonic RNA components 
takes place by the early blastocyst stage (29). 
Some proteins translated from the mRNA are Important 
In determining the rate of prelmplantatlon embryo 
development. In mice, proteins from the H-2 complex are 
Important In controlling this rate of development (2-4) and 
the levels of messenger RNA for the class I and class II 
proteins have been shown to Increase from the 2-cell to 
blastocyst stage embryos (30). 
3. Expression of H-2 proteins on prelmplantatlon embryos 
The mRNA that is transcribed by the prelmplantatlon 
embryo is also translated during prelmplantatlon. The H-2 
antigens found on prelmplantatlon mouse embryos (30-35) are 
actually synthesized by the embryo and not adsorbed to the 
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surface from the maternal system (35). 
There Is an Increase In the amount of translation of 
mRNA from the zygote to the 2-ce11 embryo and during the 
transition from the morula to the blastocyst (36,37). The 
levels of H-2 proteins present on the embryo's surface show 
a rapid Increase during the 2-cell to the blastocyst stages 
of development (33). 
C. Pregnancy and the Immune Response 
In 1953, Medawar proposed three hypotheses to explain 
the Immunological tolerance of the maternal Immune system 
for allogeneic fetal antigens (38). Medawar based his 
hypotheses on Information about Incompatible fetal red-cell 
antigens of the Rhesus series. 
The first hypothesis suggests that the fetus Is 
anatomically separated from the mother. However, recent 
evidence Indicates that the fetus Is not Isolated from the 
mother. Antigens from the embryo can cross the maternal-
fetal barrier and Induce both cellular (39-41) and humoral 
(42) responses to fetal antigens. The barrier Is also 
Ineffective In the other direction. Cells from the 
maternal Immune system have been detected in utero 
surrounding preImplantatI on embryos In murine and human 
systems (43,44). In the post-Implantation stages of 
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development, the placenta acts as a sink for antibodies to 
HHC molecules, but. In many species, It allows the passage 
of Immunoglobulins from maternal to fetal circulation (43). 
The second hypothesis suggests that the fetus Is 
antIgenlcally Immature and therefore not able to stimulate 
the maternal Immune system. However, HHC molecules are 
thought to be on the surface of prelmplantation (30-35,45-
49) and post-Implantation embryos (50). Paternal MHC 
antigens comprise 20-50% of the MHC molecules on post-
Implantation embryos (39) and are known to be present on 
prelmplantat Ion embryos (Warner et. a_L., 1987, ISU, 
unpublished observations). However, It is possible that 
the MHC antigens on embryos are not the same as those on 
adult tissues. Redman and others as cited in Johnson (51) 
have shown that unusual class I antigens exist on embryonic 
tissue. The exact nature of these molecules remains to be 
determined. 
Medawar's last hypothesis suggests that the maternal 
Immune system Is relatively Inert during pregnancy. Recent 
evidence indicates that the maternal Immune system is 
somewhat suppressed during pregnancy. During post-
imp 1 antat Ion stages of development, suppressor cells, which 
can Inhibit the generation of CTLs and the response to 
InterIeuk1n-2 by CTLs, are found in the decidua and venous 
blood (52). Cells of the placenta produce progesterone and 
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a soluble glycoprotein suppressor factor which may suppress 
CTL generation and block cytolysls of target cells at the 
concentrations found in the uterus (52). Even with these 
attempts to suppress maternal immune cells, the maternal 
system still mounts humoral (42) and cellular (39-41) 
responses to embryonic antigens. 
D. Cellular Immunology 
i. Phenotvpe and history of immune cells 
a. Cytotoxic T lymphocytes (CTLs) The first 
indication that cells were involved in the rejection of 
grafts was discovered using diffusion chambers by Mitchison 
(53). Govaerts (54) found that the cells involved in the 
rejection of a graft were from the thymus. Reif and Allan 
(55) were the first to use a serological marker, Thy-1, to 
detect differences among the classes of lymphocytes. 
Cantor and Boyse (56) separated different subclasses of T 
cells using the Ly-1 and Ly-2,3 markers. Zinkernagel and 
Doherty (14) found that CTLs bind class 1 molecules of 
target cells in conjunction with viral antigens on the cell 
surface. 
The ontology of T cells starts with a primordial 
hematolymphoid cell that arises near the head of the embryo 
and then migrates to the bone marrow (57,58). Cells (Thy-
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Lyt-1 ,2,3*, L3T4*) from the stem cell migrate to the 
cortex of the thymus, mature, and migrate to the medullary 
portion of the thymus as precursor T cells (Thy-1*, Lyt-l' 
,2,3*, L3T4*), where they develop into virgin T lymphocytes 
(Thy-1*, Lyt-1*/",2,3*, L3T4*). While in the thymus, each 
T cell's unique receptor is generated (59), and the MHC-
restriction (of the thymus) is acquired (58). Before 
leaving the thymus by way of either the bloodstream or 
lymphatic system, the T cells have developed their 
characteristic antigenic markers. Cytotoxic T lymphocytes 
(CTLs) are (Thy-1*, Lyt-1*/",2,3*, L3T4", asialo GMj"), 
while helper (humoral response) or accessory (cellular 
response) T cells are (Thy-1*, Lyt-1*,2,3", L3T4*, asialo 
GHj") (57,58). 
Mononuclear phagocytes are crucial in the activation 
of the cellular response (60-62). Macrophages and other 
antigen presenting cells (APC) are required for the uptake, 
processing, and presentation of the viral antigens on 
infected cells to accessory T lymphocytes (Ta). The 
presentation of the viral antigens is in conjunction with 
the class II antigen through a single combined entity. The 
immunogenic peptides from the viruses bind directly to the 
internal ligand of the histocompatibility antigens (63,64). 
APCs also produce a chemical signal in the form of 
interleukin-l (IL-I, 12-16 kO), which induces antigen-
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stimulated Ta cells to produce Interleukln-2 (IL-2, 15.4 
kD), which stimulates T cell proliferation. 
IL-2 acts on all T cells which possess an IL-2 
receptor. However, CTLs specific for the current virally 
Infected cells are more likely to respond since IL-2 
receptor expression requires continued antigen stimulation. 
IL-2 receptor levels peak within 24-48 hours after 
antigenic stimulation and decline to background levels 
within 7 days (65). Initial and subsequent antigenic 
stimulations of the CTL are through the T3/Ti antigen 
receptor binding directly to the virally infected cells 
( 6 0 , 6 1  ) .  
In response to a virally Infected cell, the CTL binds 
with its T cell receptor (TcR) to the viral antigen and the 
class I molecule's and/or Og domains (17). For an 
allogeneic response, the CTL's TcR binds only the foreign 
class I molecule's and/or Og domains (17). Recent work 
has led to the elucidation of the structure (66-72) and 
genomic location (73,74) of the a, B and y protein chains 
of the T cell receptor (Tl). The number and types of the 
accompanying lymphocyte function-associated antigens (T3 
and LFA) has also been determined (66,75,76). Reviews on 
the biochemistry and function of the TcR are available 
(59,77-80). 
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b. Natural killer (NK) cells Natural killer (NK) 
cells were first observed In the early 1970s when nude 
mice, which lack a thymus, were shown to have a cell 
population that Inhibited the Incidence of spontaneous 
tumors (81). Besides their anticancer activity, NK cells 
have been found to be involved in the defense against 
bacterial and viral infections, resistance to parasites, 
rejection of hemopoietic transplants, and regulation of the 
growth and/or differentiation of erythrold, myeloid, and 
lymphoid cell types (82). 
NK cells originate from a hematolymphoid stem cell In 
the bone marrow but require a second trip through the bone 
marrow to fully mature. The first stage of development 
leads to the acquisition of NK antigens and the ability to 
bind targets cells. The second stage enables the cells to 
respond to Interferon (IFN) and lyse target cells (83). 
NK cells are large granular lymphocytes that are not 
adherent or phagocytic and have an extended cytoplasm 
containing many azurophilic granules. The following are 
surface antigenic characteristics of NK cells: asialo 
GM|+, Thy and Lyt l~Z,3~ (84). 
The activity of NK cells can be modulated by many 
chemical and cellular agents. Interferons and molecules 
that Induce IFN cause an Increase in NK activity (85). 
Activation by IFN also enables NK cells to undergo multiple 
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cycles of lytic activity without becoming inactive (86). 
I nter 1 euk i n-2 increases NK activity j_n v i vo and In. vitro 
due to an increase in number (87) and in lytic activity due 
to I FN formation (88). NK activity can be suppressed by a 
macrophage-1 ike cell found at higher concentrations In both 
young and old as well as certain strains of mice (76). 
The susceptibility of tumor cells to lysis by NK cells 
has been correlated with the degree of differentiation of 
the target cell. Normal and malignant cells in the early 
stages of development are more susceptible to lysis by NK 
cells (89). Normal body cells from prenatal stages of 
development, such as fetal thymus and bone marrow cells, 
have been shown to be susceptible (90). Embryonal 
carcinoma cells (91) and tumor cells (92) at various stages 
of differentiation had decreases in susceptibility with 
Increases In maturation. 
Unlike CTLs, the target molecules for NK cells have 
not been characterized. Evidence Indicates that the NK 
target molecule may be the carbohydrate moieties on 
glycoproteins. Binding studies Indicate that mannose 6-, 
fructose 1-, and fructose 6-phosphates Interfere with the 
binding of NK cells with target cells (93). 
Once bound to the target antigens, NK cells will kill 
the target cell two ways. In the cytoplasmic granules of 
NK cells and CTLs, serine proteases cleave perforin rings 
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which then are able to punch holes In target cell membranes 
(94). NK cells also secrete NK cytotoxic factors (NKCF), 
which take up to ten hours to lyse NK sensitive cells (95-
98) . 
c. Lvmphoklne activated killer (LAK) cells Since 
the mid-1960s, attempts have been made to use the immune 
system to circumvent the use of surgery, chemotherapy, and 
radiation therapy. Initial attempts were made to produce 
specific responses by using either tumor cells or 
nonspecific stimulants to Immunize the host. However, the 
clinical trials were unsuccessful (99). 
A second method of immunotherapy Is adoptive transfer, 
which Is the transfer of active Immunological reagents, 
such as cells or immunostimulants, into the patient. The 
reagents should mediate either a direct or Indirect 
antitumor effect (100). Besides the specificity and low 
morbidity of this approach, there Is no immunosuppression 
of the patient. A review of the requirements of cells used 
In adoptive immunotherapy is shown In Table I. 
In 1980, Rosenberg's laboratory at the National Cancer 
Institute described the production of killer cells from 
lymphocytes using only the lymphokine, interleukln-2 (IL-2) 
(101-104). Lymphokine-activated killer (LAK) cells are 
able to lyse both NK susceptible or resistant tumor cells 
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Table I. Requirements of cells used In adoptive 
Immunotherapy (99) 
1. Available In large numbers (>10**). 
2. Immunologically specific for tumor. 
3. Well tolerated when adoptively transferred. 
4. Traffic to tumor j_n vivo. 
5. Capable of proliferating (and significantly expanding) 
In vivo. 
6. Probably should be autologous. 
(105,106) and, unlike other cytotoxic cells, fresh tumor 
cells (107,108). One Important characteristics of LAK 
cells Is that they do not lyse normal cells (99-108). 
Lymphokine-act1vated killer cells fit the requirements 
for use In adoptive immunotherapy (Table I). Initial 
adoptive transfer work Indicated that LAK cells are able to 
cause regression of tumors in vivo (109,110). Clinical 
trials Indicated that when recombinant IL-2 was also 
Injected, a significant Increase occurred in the regression 
of Id. vIvo tumors In mice and humans (100,111,112). 
A comparison of murine NK cells, CTLs, and LAK cells 
Indicates that each cell type is distinct. Natural killer 
cells are Thy 1 , but asialo GMj"*". CTL precursors and CTLs 
are Thy 1^, but asialo GMj". Precursors to LAK cells are 
Thy 1*/" and asialo GHj", early LAK cells are Thy 1^ and 
asialo GMj"*", while after 7 days of activation LAK cells are 
Thy 1+ and asialo GMj" (103). Lymphokine-activated killer 
cells are thought to originate from NK cells since early 
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LAK cells are phenotypically similar to NK cells, and 
cultures depleted of NK cells do not produce LAK cells 
(113). 
Lymphoklne activated killer cells are an artificial 
Immune cell which have been activated by high levels of the 
lymphoklne, interIeukIn-2. Clinical tests have begun to 
determine the Immunotherapeut1c benefit of these cells. 
2. Mechanism of 1vmphocvte-medlated cytotoxicity 
The mechanism of eel I-mediated lysis has been reviewed 
recently for both NK cells and CTLs (114-116). Except for 
minor differences mentioned later in this section, the 
mechanism for cell-mediated cytotoxicity is identical for 
NK cells and CTLs. The mechanism for LAK cell killing of 
their targets is unknown, but probably Is similar. 
a. Specific binding of the immune cell to the target 
mol ecu Ie The first step of cell-mediated cytotoxicity 
Involves the binding of the immune cell's receptor to the 
target antigen. This step clearly shows differences among 
the three cell types. CTLs bind the class I molecules of 
target cells In conjunction with the viral antigens 
(14,79), NK cells bind the carbohydrate moieties on 
glycoproteins (93), and what the LAK cells bind is unclear. 
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b. Calcium-dependent programming for Ivsis After 
the cytotoxic cell binds to the target cell, a more secure 
second binding takes place (114,117,118). CTLs use Lyt-2 
and lymphocyte functional antigens (LFA) for this binding 
(75,79,114), while NK cells use LFA and T200 (114). 
After binding to the target cell, a conformational 
change of the T3 molecule on CTLs (75,79,114) and the T200 
+ 2 
molecule on NK cells (114) triggers the release of Ca 
Ions. The release of Ca*^ causes the assemblage of 
microfilaments, which localizes the cytoplasmic organelles 
between the nucleus and the target cell (94,114). 
The organelle involved in cytolysis Is the cytoplasmic 
granules. The granules contain microtubules (94,114-116, 
119), serine proteinases (114-116,120,121), and 
endonuc1 eases (122). Once the contents of the granule are 
released Into the intracellular space, two types of 
microtubules or perforins are cleaved by the serine 
proteases. This cleavage allows the formation of 
polyperforin rings, or holes, in the target cell's membrane 
(94,114-116,119). Endonuc1 eases enter the target cell 
through these lesions and cause the chromatin to fragment 
into nucleosome-sized subunlts (122). NK cells also 
secrete NK cytotoxic factors (NKCF), which take up to ten 
hours to lyse NK sensitive cells (95-98). The effector 
cell then releases the target cell and goes on to repeat 
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the cycle. 
c. Killer cell Independent lysis Once released by 
the killer cell, target cells lyse due to NKCF or the 
lesions formed by the polyperforin rings. The lesions 
destroy the permeability barrier to small Ions, causing an 
unbalanced osmotic pressure that ruptures the cell's 
membrane (94,114-116,118,119). 
3. Cloning of cytotoxic immune cells 
From week to week, normal cultures of immune cells 
have minor differences in binding capacity and specificity. 
A method to overcome these differences would be to obtain 
clones of the cytotoxic cells. Once established, the 
characteristics of the cloned immune cells would not vary. 
However, one of the parameters for obtaining and keeping 
clones is obtaining adequate quantities of IL-2. The 
following are the methods involved in obtaining cloned 
cytotoxic immune cells. 
After the discovery of T cell growth factor or IL-2 
(123), three methods were devised to obtain long-term 
cultures of cloned Immune cells (124). The first method 
does not use IL-2, rather, it Involves the fusion of T 
cells and tumor cells to obtain cytotoxic ce I 1-hybridomas. 
Although the hybrids grow as tumors and reach large numbers 
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in a short time, they are not normal in chromosomal number 
and are very unstable. A second method Involves culturing 
the Immune cells in IL-2 alone. While fine for NK and LAK 
cells (125,126), this method causes chromosomal 
abnormalities in CTLs. The third method, repeated 
stimulation with IL-2 and stimulator cells (114,125,127), 
Is much closer to conditions found jji vIvo and Is the 
method of choice in most laboratories. 
Three methods to obtain clones of long term cultures 
of the Immune cells are available. The first method Is 
limiting dilution (125). Two days after an in vitro 
stimulation, CTLs are suspended In medium containing IL-2 
and then added at concentrations of less than one cell per 
well to microtlter plates containing irradiated stimulator 
cells. Every three days, IL-2 is added to the wells, while 
fresh irradiated stimulator cells are added once a week. 
After 10-14 days, the plates can be checked for the 
presence of effector cells. By repeated subcloning and 
through the use of the Poisson probability distribution 
(125) or the method of Vose (127), pure clones can be 
obta i ned. 
The second method Is the soft agar technique 
( 125, 128). Two days after an l_n_ vitro stimulation, CTLs 
are suspended In 0.3% soft agar which contains 2x medium, 
IL-2, and stimulator cells. This mixture is added to an 
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equal volume of 0.75% bacto-agar and then plated In a petrl 
plate. After 10-14 days, individual colonies can be 
visualized, removed, and recloned. 
The third method uses a fluorescent-activated cell 
sorter (129). New models, such as Coulter's EPICS, have 
adaptors which allow autocloning (130). The general method 
of limiting dilution is used except the autocloner adds the 
cells. Under the supervision of a good technician, the 
autocloner will specifically place one cell per well with a 
precision which leaves statisticians speechless (131). 
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III. MATERIALS AND METHODS 
A. Materials 
1. Mice 
The A/J, BIO.BR, BIO.02, C57BL/6, C57BL/10Sn and CBA 
inbred mouse strains were obtained from the Jackson 
Laboratory, Bar Harbor, ME. The CF-1 outbred mouse strain 
was obtained from the Charles River Facilities at Portage, 
Ml. Mice were housed In a day/night controlled room (14-
hour day, 10-hour night). 
2. Buffers, solutions, and culture media 
The recipes and abbreviations for the buffers, 
solutions, and culture media used for the research in this 
dissertation are listed in Table 11. 
Table 11. Buffers, solutions and culture media 
Name Components Source 
Chromium-51 sterile sodium chromate-51 New England 
(^'cr) in normal saline (pH =» 8.0) Nuclear 
Concanaval1n A 
(Con A) adjusted to 5 mg/mL in PBS Sigma 
CTL Medium Oulbecco's modified Eagle medium GIBCO 
(CTLM, 142) supplemented with the following: 
2 % fetal calf serum HyClone 
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Table II. continued 
Name Components Source 
or 2 % NuSerum Collaborative 
Research 
1 X antibiotics/antimycotics GI BCO 
10 mM HOPS (morpholinopropane-
sulfonic acid) Si gma 
5 X lO" M 6-mercaptoethanol Bi oRad 
0.27 mM L-asparagine (tissue 
culture grade) Si gma 
1.48 mM L-glutamine (tissue 
culture grade) Si gma 
0.67 mM L-arginine (tissue 
culture grade) Si gma 
Supplemented Oulbecco's modified Eagle medium GIBCO 
DMEM supplemented with the following: 
(DMEM+) 10 X fetal calf serum HyClone 
or 2 % NuSerum Collaborative 
Research 
1 X antibiotics/antimycotics GIBCO 
Ficoll- Stock solutions: 
Hypaque 9 g Fi col I powder in 100 mL 
(F-H) distilled ddHgO 
34 g Hypaque powder in 100 mL 
distiI led ddHpO 
For density = T.084 
60X Ficoll and 40X Hypaque 
Adjust to specific gravity with 
hygrometer 
Store in freezer away from 
Ii ght. 
Wi nthrop 
-Breon 
Pharmac i a 
Tritiated stock solution: [methyl-^H-T] New England 
Thymidine thymidine (20 Ci/mole, I mCi/ml) Nuclear 
(^H-TdR) Adjust to 8 uCi/mL by adding 200 uL 
of stock solution to 25 mL of WB medium 
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Table II. continued 
Name Components Source 
Hank's 
BaIanced 
Salt 
So Iut1 on 
(H8SS) 
0.19 g CaClp'Z H_0 
0.4 g KCl 
0.06 g KH.PO, 
0.10 g MgClp*6 
0.10 g MgSOj'7 
8.00 g NaCI 
H,0 
HgO 
0.35 g NaHCO-
0.048 g Na-HPO, 
1.00 g Glucose 
0.01 g Phenol red 
Dilute to 1 liter with ddH.O 
Adjust to pH 7.3. 
recipe from 
GIBCO 
cata1ogue, 
1978 
Human 
Chor ionic 
Gonadotropin 
(hCG) 
stock solution: 
1 vial (5000 lU) 
10 mL saline 
Store at 4°C 
Bring to working concentrations 
with saline 
NCI 
LBRH Dulbecco's modified Eagle medium 
Medium supplemented with the following 
(138) 10 % fetal calf serum 
(LDMEM+) or 10% NuSerum 
1% (lOOX) nonessential 
amino acids GIBCO 
1% (ZOOmM) L-glutamine 
10 mM HOPS 
10% NCTC 109 [NCTC 135 with 
0.26 g/1 L-cysteine] 
1% Solution I 
0.08 g/100 ml insulin 
1.32 g/100 ml oxaloacetic acid 
0.55 g/100 ml sodium pyruvate] 
GIBCO 
: 
HyCI one 
Co 1 Iaborat i ve 
Research 
S i gma 
S i gma 
GIBCO 
S i gma 
S i gma 
S i gma 
GIBCO 
LAK RPHI medium supplemented with GIBCO 
Medium the following: 
(LRPHI+) 10 % fetal calf serum HyClone 
(140) 
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Table II. continued 
Name Components Source 
or 
5 X 
1% 
1% 
1 % 
10% NuSerum 
5 10 ^ M 6-mercaptoethanol 
(lOOX) nonessential amino acids 
(200 mM) L-glutamine 
antibiotics/antimycotics 
Co I 1aborat i ve 
Research 
BioRad 
GIBCO 
S i gma 
GIBCO 
Mitomycin c 0.5 mg/ml mitomycin c In RPMI+ SI gma 
Phosphate 
Buffered 
Sal I ne 
(PBS) 
0.45 g NaH_P0.'H_0 
0.95 g Na.RPO: 
7.40 g NaCl 
Dilute to 1 liter with ddH.O 
Adjust to pH 7.0 
PMA Phorbol-12-myrlstate-13-acetate 
adjusted to 1 mg/mL in acetone 
then adjusted to 1 wg/mL In PBS 
SI gma 
Pregnant stock solution: 
Mare 1 vial (2000 units) 
Serum 4 mL saline 
(PMS) Store at -90 C 
Bring to working 
with sal I ne 
S i gma 
concentrât Ions 
Supplement RPNI 1640 medium supplemented GIBCO 
RPMI with the following: 
(RPMI+) 10 % fetal calf serum HyClone 
or 10% NuSerum Collaborative 
Research 
1 % antibiotics/antimycotics GIBCO 
Saline 0.15 M NaCl (8.76 g) In 
1 1iter ddHgO 
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Table II. continued 
Name Components Source 
Toluene 20.5 g PRO (2,4-diphenyloxazole, 
Fluor scintillation grade) Fisher 
1.03 g POPOP (P-bls-[2-(5-
phenyloxazolyl)]-benzene, 
scintillation grade) Fisher 
4.0 L toluene 
stir overnight. 
Tyrode's 
Acid 
Water 
(149) 
0.4% PVP (polyvinylpyrrolidone) 
in ddHpO 
Adjust^pH to 2.5 with HCI. 
GAF 
Whitten 
and 
Bigger's 
Culture 
Medium 
(148) 
WB Medium 
0.162 
0.356 
5.140 
0.294 
2.106 
1 . 0 0 0  
0.527 
0.075 
0.050 
3.700 
1.0 mL 
0.036 g 
Bring to 
g 
g 
g 
g 
g 
g 
g 
g 
g 
g 
HgO 
KHpPOj 
KCf 
NaCI 
MgSO •• 
NaHCOg 
GIucose 
Ca Lactate 
Pen Ici I I in G, K salt 
Streptomyc i n 
Na Lactate, 60% syrup 
1% Phenol red 
Na Pyruvate 
1 Iiter with ddH20. 
Gas with 
to 30 m 
Add 3.00 
(BSA). 
Millipore fiI ter 
and store at 
CO- in air for 15 
nuCes. 
g Bovine Serum Albumin 
Sigma 
S i gma 
S i gma 
GIBCO 
GIBCO 
4°C. 
(.85 microns) 
White Blood 3.0 % glacial acetic acid 
Cell 0.01 % crystal violet 
Diluting bring to 100 mL with ddH-O 
Solution 
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3. Cell I Ines 
The tumor cell lines listed In Table III, below, were 
Incubated at 37®C In 7% COg In air. The media used to 
maintain these cells are described In Table II, above. 
4. Antibodies 
The abbreviations and sources of the antibodies used 
In the research for this dissertation are listed In Table 
IV, below. 
Table III. Ce I I IInes 
Cell H-2 
Line Haplotype Media Source Reference 
Yac- I a RPMI + R. B. Herberman * 132 
EL-4 b DMEM+ ATCC^ (39) 133 
P815 d RPMI + ATCC (64) 134 
HO-13-4 d OMEM+ ATCC (99) 135 
53-6.72 rat LDHEM+ ATCC (104) 136 
53-7.313 rat DMEH+ ATCC (105) 136 
N-S.2. 1 d DMEM+ ATCC (110) 137 
LBRH-33-5A4 k LDMEM+ ATCC (155) 138 
EL-4.IL-2 b DMEM+ ATCC ( 181) 139 
1 . 
2 .  
National Cancer Institute. 
ATCC = American Type Culture Collection, Rockville, MD. 
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Table IV. Antibodies 
Ant i body 
Specificity 
Ig 
Class Designation Source Reference 
anti-Thy 1.2 mouse IgH HO-13-4 
anti-Lyt 2 rat IgG 2a 53-6.72 
anti-Lyt 1 rat IgG 2a 53-7.313 
antl-SRBC mouse IgMic N-S.2.1 
ATCC* (99) 
ATCC (104) 
ATCC (105) 
ATCC (110) 
135 
136 
136 
137 
anti-asialo GH, rabbit polyclonal Wako 140 
1. ATCC = American Type Culture Collection, Rockville, MD. 
2. Wako Pure Chemical Industries, Ltd., Dallas, TX. 
1. Isolation of spleen cells 
The spleen cells were isolated using F1 col I-Hypaque 
differential centrifugation as described by Boyum (141). 
Basically, the spleen was removed, cut in half, added to 4-
8 mL of RPMI+, and placed Into a 10 mL beaker. The spleen 
parts were then placed on a 40 gauge mesh screen and 
pressed Into the beaker with a 5 mL syringe plunger. A 
pipet was used to rinse the spleen cells from the screen 
and disperse the cell clumps within the beaker. 
Next, the cells were carefully layered over 8 mL of F-
H [6 = 1.084] in a 15 mL centrifuge tube. The cells were 
centrifuged for 10 minutes at 500 x g, removed from the 
B. Preparation of Effector Cells 
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Interface, and placed Into a clean centrifuge tube. After 
three washes In RPMI+, the cells were counted and adjusted 
to proper concentrations. 
2. Production of CTLs 
CTLs specific to H-2 antigens were generated following 
the method of Glasebrook and Fitch (142). Primary, 
secondary, and tertiary stimulations were performed with 
congenic strains: C57BL/10Sn spleen cells stimulated 
BIO.BR cells (antl-H-2^ CTL), whereas BIO.02 spleen cells 
stimulated C57BL/10Sn cells (antI-H-2^ CTL). All the 
stimulations used CTLM (see Table II). 
The procedures for the cell Isolation were done with 
autoclaved Instruments in a sterile hood. The mice were 
killed. Immersed In 70% ethanol, and placed on a paper 
towel In the hood. The spleens were aseptlcally removed, 
cut In half, and added to 15-20 mL of CTLM In a 30 mL 
beaker. The spleen parts were then placed on a 40-gauge 
mesh screen and pressed Into the beaker with a 5 mL syringe 
plunger. A cotton-plugged pipet was used to rinse the 
spleen cells from the screen and disperse the cell clumps 
within the beaker. 
The cells to be used as stimulators were transferred 
to a 100 mL bottle. They were adjusted to 5 x 10® cells/mL 
with CTLM. After the cells were counted with white blood 
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cell diluting solution, the cells to be used as responders 
In the primary stimulation were transferred to 500 mL 
bottles and adjusted to 5 x 10^ cells/mL with CTLH. 
The stimulator cells for each stimulation were 
irradiated with 1400 rads from a Cobalt-60 source at either 
the Nuclear Engineering Building, ISU, or the Cobalt 
therapy department, Mary Greeley Hospital. 
For the primary stimulation, equal volumes of 
stimulator cells were mixed with responder cells such that 
the volume did not exceed 150 mL per bottle. The bottles 
were Incubated upright for 14 days at 37°C in 1% COg in 
air. 
Responder CTLs for the secondary stimulation were the 
cells from the previous primary stimulation. The cells 
were centrlfuged, brought to 50 mL in fresh CTLM, and 
counted. The cell concentrations were adjusted to 
approximately 2 x 10^ cells/mL in fresh CTLM. Fresh 
stimulator cells (5 x 10^ cells/mL) were then added to an 
equal volume, and the cell mix was added to 500 mL bottles 
such that the volume did not exceed 150 mL per bottle. The 
bottles were incubated upright for 7 days at 37°C in 7% COg 
in air. 
Responder CTLs for tertiary stimulation were cells 
from the previous secondary stimulation. The CTLs were 
centrlfuged, brought to 50 mL In fresh CTLM, and counted. 
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Next, the cell concentrations were adjusted to 
approximately 2 x 10^ cells/mL In fresh CTLM. Fresh 
stimulator cells (5 x 10^ cells/mL) were added to an equal 
volume, and the cell mix was added to 500 mL bottles such 
that the volume did not exceed 150 mL per bottle. The 
bottles were Incubated upright for 3 days at 37®C, 7% COg 
In air and then used In either a ^'cr release assay or a 
MELIA. 
3. Isolation of natural killer (NK) cells 
NK cells were Isolated using the procedures In the 
Isolation of spleen cells section. Spleen cells from the 
CBA and A/J mouse strains were used as the positive and 
negative sources of NK cells, respectively (143). 
4. Production of Ivmphoklne activated killer (LAK) cells 
a. Production of interleukin-2 (lL-2) The lL-2 
from the LBRM cell line was produced following the 
procedures of Gil lis et. a_l_. (138). The LBRM cells were 
adjusted to 2 x 10® cells/mL in RPMI+. Next, an equal 
volume of con A at 40 wg/mL In RPMI+ was added to the 
cells. After a one-hour Incubation at 37°C in 7% COg in 
air, the cells were centrifuged; the supernatant was then 
replaced with an equal volume of fresh RPMI+ to eliminate 
con A in final IL-2. After a 24-hour Incubation at 37°C in 
35 
7% COg in air, the cells were centrifuged and the 
supernatant was collected for use as IL-2. 
IL-2 from the EL-4.IL-2 cell line was produced 
following the procedures of Farrar e^ aj_. (139). The EL-
4.IL-2 cells were adjusted to 2 x 10^ cells/mL in RPMI 
supplemented with 1% PCS and antibiotics/antimycotics 
(RPMl+1). Next, an equal volume of PMA at 40 ng/ml in 
RPMl+1 was added to the cells. After a one-hour incubation 
at 37®C in 1% COg in air, the cells were centrifuged; the 
supernatant was then replaced with an equal volume of 
RPMI+1 to eliminate PMA in the final IL-2. After a 24-hour 
incubation at 37®C in 7% COg in air, the supernatant was 
collected for use as IL-2. 
The assay to determine the activity of IL-2 in the 
supernatants followed a modified procedure of Gil lis et al. 
(144). Duplicate serial dilutions (50 yL) of the 
supernatant were made Into 50 yL of RPMI+ in 96 well plates 
(Flow Labs). Next, CTLs at 2 x 10^ cells/mL were added in 
50 uL aliquots to all the wells. After 24 hours, 100 uL of 
^H-TdR (8 wCi/mL) were added to all the wells. After 6 
hours of incubation at 37®C in 7% CO^ in air, the wells 
were harvested with a cell harvester (Skatron) and the cpm 
per disk were then determined in toluene fluor using a 
liquid scintillation counter. 
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b. Generation of LAK cells LAK cells were 
generated following the procedures of Mule' et al. (145). 
Lymphocytes from spleens were isolated over F-H to remove 
erythrocytes and then were adjusted to 3 x 10^ cells/mL in 
LRPMI+. lL-2 from Sigma (at > 25 U/mL) or IL-2 prepared 
from LBRM or EL-4.IL-2 cell line supernatants (final 
dilution having the highest activity) was added to the 
cells. Next, the cells were incubated in supine, 25 cm 
tissue culture flasks (CornIngware) for 72 hours. After 
dead cells were removed by F-H centrifugatIon, the LAK 
cells were washed three times in RPM1+ and then adjusted to 
proper concentrations. 
C. Manipulation of Effector Cells. 
I. ^^Chromium release assay 
The procedures used for the Incorporation of 
^^chromlum (^'cr) Into target cells and for the ^'cr 
release assay are modifications of those used by Klessling 
et a 1. (143). For the incorporation of ^'cr, 10^ to 10® 
target cells were centrlfuged In 15 mL disposable 
centrifuge tubes (CornIngware), the supernatant removed, 
and the cells mixed with 100 uL of FCS and 200 to 300 uCi 
of ^'cr. After a one-hour incubation at 37®C In 7% COg in 
air, the cells were washed three times with RPMI+ and then 
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adjusted to a concentration of 2 x 10^ cells/mL. 
While the target cells were Incubating, the effector 
cells and control spleen cells were Isolated by F-H density 
gradient centrlfugatIon. The effector cells were then 
washed three times with RPHI+ and adjusted to proper 
effector to target ratios. 
The assay was performed In 12 x 75 mm test tubes. 
Allquots of 100 wL of effector cells, RPMI+, and 1 M HCl 
were added to the test tubes designated experimental (Exp), 
spontaneous (Spon), and maximal (Max) release tubes, 
respectively. Target cells were then added to each tube in 
50 wL allquots. 
The assay was terminated after a four-hour Incubation 
at 37®C In 7% COg In air by adding one mL of RPHI+ to each 
Exp and Spon tube, and 1 mL of 1 M HCl to each Max tube. 
All tubes were centrlfuged at 200 x g for 5 minutes. Next, 
one-half of the supernatant was removed from each tube and 
placed Into a second tube. The contents of the first tube 
were designated "pellet" and the contents of the second 
tube were designated "supernatant." The tubes were counted 
In a Tracor 1197 automatic y-counter. 
The percent chromium release was then calculated for 
use In the determination of the percent specific lysis, as 
fol lows : 
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% Chromium Release (%CR) = 100% x (2 x supernate com) 
(supernate cpm + pellet cpm) 
% Specific Lysis = 100% x (Exp(tCR) - Spon(%CR)) 
(Max(%CR) - Spon(%CR)) 
2. Treatment of cells with mitomycin c 
For the NK MELIA, the blastocysts needed to be 
Incubated with NK cells while the radioactive thymidine was 
present for optimum killing of the embryonic targets and 
for optimum uptake of ^H-TdR. Since thymidine uptake by 
the spleen cells would mask that of the embryos, the DNA 
polymerase activity of the spleen cells was inhibited with 
mitomycin c. 
To determine the best concentration to use, spleen 
cells at 1 x 10^ to 4 x 10^ cells/mL were Incubated for one 
hour with increasing levels of mitomycin c (0 to lOOwg/mL), 
washed three times with RPM1+, and Incubated In 96 well 
microtiter plates for 4 hours with 100 uL ^H-TdR (8 uCI/mL) 
in RPMI+ at 37®C In 7% COg |n air. The wells were 
harvested with a cell harvester (Skatron), and the cpm per 
disk were determined in toluene flour using a liquid 
scintillation counter. 
For mitomycin c treatment prior to the NK MELIA, the 
cells were adjusted to 5 x 10^ cells/mL In RPMI+. An 
aliquot of a stock solution of mitomycin c was added to the 
cells to make a final concentration of 100 ug/mL of 
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mitomycin c. After a one-hour incubation, the cells were 
washed three times In RPMI+, counted, and adjusted to 
proper concentrations. Cells to be used In the HELIA were 
washed once again in WB medium. 
3. Treatment of cells with antibody alone 
The phenotype of the effector cells was determined 
using antiserum and a ^ 'cr release assay following the 
technique of MacDonald et. a_L. (146). Dead cells were 
removed from the effector population by F-H centrIfugatI on. 
After two washes In RPMI+, the effector cells were washed 
once again In 15 mL of the monoclonal antibody (mAb). 
Next, the pellet was brought up In 0.6 mL of fresh mAb; 0.3 
mL of this cell mix was then used to serially dilute the 
cells into 0.3 mL mAb aliquots. The cells were incubated 
for one-half hour at 37°C In 7% COg in air and then divided 
among three test tubes. Target cells were added to the 
test tubes, and the ^'cr release assay procedures were then 
fol 1 owed. 
4. Treatment of cells with antibody and complement (C) 
The second method to determine the phenotype of the 
effector cells used antiserum, complement, and a ^ 'cr 
release assay. The monoclonal antibodies (1:10) were added 
In O.I mL aliquots to pellets of 1 x 10^ cells in 1.5 mL 
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tnicrofuge tubes. An aliquot of 0.1 mL of guinea pig 
complement (1:2) was added to the tubes, which were 
incubated for one hour at 37°C in 7% CO^ in air. After the 
incubation, the cells were washed three times with RPMI+ 
and used in a ^'cr release assay at varying E:T ratios. 
D. Manipulation of Embryos 
1. Superovulation of mice 
Embryos were collected from superovu1ated B10.D2, 
C57BL/6, and CF-1 mice. For the inbred strains, mature 
mice (older than 8 weeks) were injected with 5 I.U. PMS at 
the 9^*^ hour of the light cycle, followed 48 hours later by 
10 I.U. hCG. Prepubertal mice (under 4 weeks of age) 
received half of the above doses. Following the same 
schedule, CF-1 females were injected with 5 I.U. PMS and 5 
1.U. hCG. Each female was then placed with a single male 
two hours after the hCG injection and checked for a vaginal 
plug the following morning. 
2. Isolation of embryos 
Embryos were isolated from the uterine, horns of mice 
following the technique of Rafferty (147). Embryos were 
collected into Whitten and Biggers (148) medium at 93 hours 
post-hCG, which corresponds to the blastocyst stage of 
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development. In some experiments BIO.02 embryos were 
collected 85 post-hCG. 
The uterine horns were removed from the mouse and, to 
prevent drying. Immediately placed Into 0.5 mL of WB medium 
In an embryo dish (one Inch, square concave slide, Carolina 
Biological). After the uterine horns were removed from the 
mice, five horns were placed in each embryo dish. A 30 
gauge needle was placed on the end of a 1 mL syringe that 
was previously loaded with WB medium. Each horn was 
Injected with at least 0.2 mL of WB medium to flush the 
embryos. After the uterine horns were flushed, the embryos 
were collected Into a single embryo dish in preparation for 
further manipulations. 
3. Removal of zonae pellucldae with Tvrode's solution 
In the experiments requiring the removal of the zonae 
pellucldae, embryos were washed in WB without BSA and 
treated with Tyrode's solution (149) for 10-20 seconds. 
After the zonae pellucldae were removed, the embryos were 
immediately transferred to fresh WB medium and then washed 
three times in WB medium. 
4. Tritiated thymidine (^H-TdR) Incorporation 
Assays were performed In 96-wel1 plates (Flow Labs). 
Into each well the following were added in the order 
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listed: 50 uL of WB medium, embryos, and an aliquot of 50 
yL of either WB medium alone or the experimental medium (or 
cells) in WB medIum. 
After the embryos were Incubated, 100 wL of ^H-TdR 
(8 wCi/mL) were added to each well to give a final 
concentration of ^H-TdR of 4 uCi/mL. After 8 hours of 
incubation at 37®C In 7% COg in air, the wells were 
harvested with a cell harvester (Skatron). The cpm per 
disk were determined in toluene flour using a liquid 
scintillation counter. The incorporation of ^H-TdR Into 
embryonic DNA was used as an objective assay of embryo 
viabiIity (149,151). 
The percent inhibition of ^H-TdR incorporation was 
calculated as follows: 
100% - loot X (exp com/number of exp embryos) 
(control cpm/number of control embryos) 
The percent of control was calculated as follows: 
100% X (exp cpm/number of exp embryos) 
(control cpm/number of control embryos) 
E. Mixed Embryo Leukocyte Interaction Assay (MELIA) 
I. CTL MELIA 
The CTLs for the MELIA were isolated over 
F1 col 1-Hypaque as in the ^'cr release assay. After the 
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third wash In RPMI+, the cells were washed In WB medium. 
Assays were performed within the alternating circular 
ridges on the lids of TerasakI monoclonal cluster plates 
(Costar). To allow for air exchange, the lids were 
punctured around the periphery with a hot needle. To each 
circular ridge, the following were added In the order 
listed: 15 uL of WB medium, individual embryos 
(transferred with a micropipet), and CTLs or control cells 
in 10 uL of WB medium. The plates were then Inverted and 
the hanging drop cultures were Incubated in a humidified 
chamber at 37®C In 7% COg in air for four hours. 
Next, the embryos receiving Identical treatment were 
placed in a single watch glass containing WB medium, where 
the total number of embryos and the number of blastocoels 
were counted. After two more washes, the embryos were 
incubated in ^H-TdR for 8 hours at 37®C in 7% COg in air 
and were harvested, as explained In Trittated thymidine 
(^H-TdR) incorporation. 
The percent Inhibition of relative blastocoel 
retention was calculated as follows: 
100% - loot x (No. of exp blastocoel/No. of exp embrvos) 
(No. of control blastocoel/No. of control embryos) 
When the data from the Tables were combined and 
expressed In Figures, weighted means and standard errors of 
the mean were used. 
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2. NK and LAK MELlAs 
Assays were performed In 96-well plates (Flow Labs). 
To each well, the following were added In the order listed: 
50 yL of WB medium, five embryos, and 50 wL of cells 
pretreated with mitomycin c In WB medium, or WB medium 
alone. The effector to target ratio was based on each 
embryo consisting of 40 cells (150). After a four-hour 
Incubation, the second part of the Tritlated thymidine (^H-
TdR) Incorporation procedure was followed. 
The calculations used for the NK and LAK MELIAs were 
as fol lows: 
Inhibition ^H-TdR Incorporation: 
100% -  l o o t  X  (exp com/number of exp embryos) 
(control cpm/number of control embryos) 
Inhibition as a Percent of A/J: 
100% - 100% X (Inhibition ^-TdR Incorporation for exp) 
Inhibition H-TdR Incorporation for A/J 
There were four types of NK experiments performed. 
Type I used the medium control, A/J control cells and CBA 
cells. Type II used the medium control, and A/J control 
cells. Type III used the medium control, and CBA cells. 
Type IV used A/J control cells, and CBA cells. 
When the data from the Tables were combined and 
expressed In Figures, weighted means and standard errors of 
the mean were used. 
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IV. RESULTS 
A. Parameters for CTL ^'cr Release Assay 
1. Time course and effector to target (E:T) ratio 
The first experiments were designed to determine the 
time required for the CTLs to lyse tumor cell line target 
cells in a ^'cr-release assay. The figures for antl-H-2^ 
CTLs (Figure 1) and anti-H-2^ CTLs (Figure 2) both show the 
specific lysis of the target cells at different times and 
E:T ratios. The results Indicate that at each E:T ratio 
the lysis of the target tumor cells increased with time, 
with maximal lysis achieved at 4 to 6 hours. For 
subsequent experiments, an assay period of 4 hours was 
chosen. 
These experiments also determined the optimal E:T 
ratios required for the CTLs to lyse tumor cell lines in a 
4-hour ^'cr release assay. The figures for both anti-H-2^ 
CTLs (Figure 1) and anti-H-2^ CTLs (Figure 2) show the 
specific lysis of the target cells at different E:T ratios. 
The results indicate that the optimal E;T ratios were from 
50:1 to 400:1 with no Increase In specific lysis at higher 
E:T ratios. Therefore, E:T ratios for the MELIA were set 
at 50:1 to 400:1. 
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Figure 1. Time dependence of antl-H-2^ CTL lysis of EL-4 
(H-2^) target cells. CTLs were tested against 
tumor cells In a ^'cr release assay. The curves 
were generated for 2-hour ( • ), 4-hour ( m), 6-
hour (&)t and 8-hour (a) incubation times. 
The control cells ( x ) were nonimmune spleen 
cells Incubated for 4-hours with the target 
cells 
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Figure 2. Time dependence of antl-H-2^ CTL lysis of P815 
(H-2^) target cells. CTLs were tested against 
tumor cells In a ®'cr release assay. The curves 
were generated for 2-hour (O)» 4-hour (#), 6-
hour (©). and 8-hour (0) Incubation times. 
The control cells ( x ) were nonimmune spleen 
cells Incubated for 4-hours with the target 
cells 
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2. Specificity of CTLs towards tumor cells 
To test the specificity of the CTLs, an assay was done 
with the EL-4 tumor line as the target cells. The 
anti-H-2^ CTLs showed high specific lysis while the anti-
H-2^ CTLs showed low specific lysis (Figure 3). The 
opposite results were found when the P815 tumor cells 
(H-2^) were used in an identical experiment (Figure 4). 
Thus, the specificity of the CTLs was as expected. 
3. Removal of CTL activity with antibody 
a. Thy 1 and C These experiments were designed 
to determine whether the effector cells were T cells. 
Effector cells were preincubated with anti-Thy 1.2 
monoclonal antibody and complement (C) or anti-SRBC mAb 
B 1 
and C before use in a Cr release assay. The cytolytic 
activity was inhibited for both anti-H-2^ (Figure 5) and 
anti-H-2'^ CTLs (Figure 6) at a dilution of 1:10, but 
returned at higher dilutions. Thus, the effector cells 
were Indeed T cells. 
b. Lyt 1. 2 These experiments were designed to 
determine whether the effector cells were CTLs. Effector 
cells were preincubated with anti-Lyt 2 or anti-Lyt 1 
monoclonal antibody before use in a ^'cr release assay. 
The cytolytic activity was inhibited by anti-Lyt 2 mAb for 
49 
70-1 
1.6 3.2 6.2 12.5 25 50 100 
Effector : Target 
Figure 3. Specificity of the CTLs against EL-4 (H-2^) 
tumor cell line. CTLs [anti-H-2^ ( • ) or anti-
H-2^ (•)] and control cells [nonimmune spleen 
cells (X)] were tested in a ^'cr release assay 
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Figure 4. Specificity of CTLs against the P815 (H-2^) 
tumor cell line. CTLs [antl-H-2^ ( • ) or antl-
H-2^ (•)] and control cells [nonimmune spleen 
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cells( X )] were tested In a Cr release assay 
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Figure 5. Titration of anti-Thy 1.2 monoclonal antibody. 
Anti-H-2^ CTLs were incubated with anti-Thy 1.2 
( • ) or anti-SRBC ( m) monoclonal antibodies 
plus complement at various dilutions or with 
RPMI + (D). The cells were washed and then 
tested against EL-4 (H-2^) tumor cells In a 
release assay. Nonimmune spleen cells were used 
as control cells ( x) 
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of ant 1-Thy 1.2 monoclonal antibody. Titration 
Ant1-H-2^ CTLs were Incubated with antl-Thy 1.2 
(•) or antl-SRBC (®) monoclonal antibodies 
plus complement at various dilutions or with 
RPMI+ (O). The cells were washed and then 
tested against P815 (H-2^) tumor cells in a ^'cr 
release assay. Nonimmune spleen cells were used 
as control cells ( x ) 
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both ant1-H-2b CTLs (Figure 7) and antl-H-2*^ CTLs (Figure 
8), but antl-Lyt 1 mAb had no effect on the activity. The 
antl-Lyt 2 did not completely eliminate all the antl-H-2^ 
CTL activity (Figure 0). The reason for this is unclear, 
but perhaps anti-H-2^ CTLs have a higher density of Lyt 2 
ant 1 gens. 
c. Asialo GMI and C' These experiments were 
designed to determine whether the effector cells were NK 
cells. The effector cells were pretreated with anti-asialo 
GMj and C before use In a ^'cr release assay. No effect 
on cytolytic activity was found for either anti-H-2^ CTLs 
(Figure 9) or antl-H-2^ CTLs (Figure 10), whereas anti-Thy 
1.2 and C eliminated or reduced the cytolytic activity. 
Thus, the effector cells were not NK cells. 
4. The effect of Whitten and Biggers medium on CTL 
act ivitv 
Because mouse embryos require WB medium to grow, a 
^'cr release assay was done in WB medium or RPM1+ to see if 
antl-H-2^ CTLs would lyse EL-4 tumor cells while in WB 
medium. The experiment was done with only anti-H-2'' CTLs 
since both types of CTLs react similarly. The results 
(Figure 11) indicate that the specific lysis of EL-4 tumor 
cells was the same whether the assay was done In RPMI+ or 
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Figure 7. Inhibition of CTL activity with Lyt 2 antibody. 
Antl-H-2^ CTLs were preincubated with antl-Lyt 2 
(ffl ) or antl-Lyt I ( H) monoclonal antibody 
before use In a ^^Cr release assay. The cells 
were tested against EL-4 (H-2^) tumor cells 
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Figure 8. Inhibition of CTL activity with Lyt 2 antibody. 
Anti-H-2^ CTLs were preincubated with anti-Lyt 2 
(©) or anti-Lyt 1 (0) monoclonal antibody 
before use in a ^'cr release assay. The cells 
were tested against P815 (H-2^) tumor cells 
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Figure 9. Treatment of CTLs with antl-aslalo GMj antibody. 
Antl-H-2^ CTLs were Incubated with antl-aslalo 
GHl polyclonal (a) or ant I-Thy 1.2 (•) 
monoclonal antibody plus complement at various 
dilutions or with RPMI+ (•). The cells were 
washed and then tested against EL-4. (H-'2^) tumor 
cells in a ^'cr release assay. Nonimmune spleen 
cells were used as control cells (x ) 
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Figure 10. Treatment of CTLs with anti-asialo GMj 
antibody. Anti-H-2^ CTLs were incubated with 
anti-asialo GMl polyclonal (Z) or anti-Thy 1.2 
monoclonal (•) antibody plus complement at 
various dilutions or with RPMI+ (O). The 
cells were washed and then tested against P815 
d 51 (H-2 ) tumor cells In a Cr release assay. 
Nonimmune spleen cells were used as control 
cells ( X) 
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Figure 11. The effect of Whitten and Biggers medium on CTL 
activity. Antl-H-2^ CTLs were tested against 
b 51 
EL-4 (H-2 ) tumor cells In a Cr release assay 
In either KB medium (*) or RPMI+ (•). Non-
Immune spleen cells were also Incubated in 
either WB medium (+) or RPM1+ (x ) 
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in WB medium. Therefore, the CTLs would be able to 
function properly In the CTL MELIA. 
B. Parameters for NK ^'cr Release Assay 
I. Strain differences and EiT ratio 
The first experiments were done to determine which 
strain to use as the positive and negative controls. A 
four-hour ^^Cr release assay was performed with CBA and A/J 
spleen cells as the effector cells and with Yac-1 tumor 
cell line—which is susceptible to NK lysis—as the target 
cells (143). The results (Figure 12) Indicate that the 
spleen cells from the CBA strain have a higher NK activity 
than the spleen cells from the A/J strain. 
An experiment was done to determine the optimal E:T 
ratios required for the NK cells to lyse the Yac-1 tumor 
line in a four-hour ^'cr release assay. NK activity from 
the CBA strain peaked at an effector to target ratio 
between 100:1 and 200:1, with higher E:T ratios actually 
causing an inhibition of activity (Figure 12). Therefore, 
spleen cells from CBA mice were used as NK cells, while A/J 
cells were the negative control at E:T ratios of 50:1 to 
200:1. 
60 
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Figure 12. Strain differences In NK activity. A four-hour 
^^Cr release assay was performed with CBA <A) 
and A/J (x) spleen cells at various E:T ratios 
against the NK sensitive, Yac-1 tumor cell line 
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2. Time course for NK cell Ivsis of target cells 
The next experiment was done to determine the time 
required for NK cells to lyse Yac-1 tumor cells In a ^'cr 
release assay. Figure 13 shows the specific lysis of the 
Yac-1 cells at different times and E:T ratios. The results 
Indicate that at each E:T ratio, the killing of Yac-1 
Increased with time. Because of these results and the fact 
that CF-l blastocysts incorporate the maximum amount of 
radioactivity into their DNA with a 4-hour preincubation 
followed by an 8-hour incubation In ^H-thymidlne (150), a 
12-hour assay period was chosen for the NK MELIA. 
3. Removal of NK cell activity with antibody 
a. Thy 1 and C These experiments were designed 
to determine whether the effector cells were T cells. 
Effector cells were prelncubated with anti-Thy 1.2 
monoclonal antibody and complement (C) or antl-SRBC mAb 
and C before use In a ^'cr release assay against Yac-1 
tumor cells. The results (Figure 14) indicate that the 
cytolytic activity was not inhibited at the dilution that 
inhibited CTL activity (1:10, Figures 5 and 6). Thus, the 
effector cells were not T cells. 
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Time dependence of NK cell lysis of Yac-I 
target cells. NK cells were tested for various 
Incubation times against Yac-1 tumor cells in a 
^'cr release assay. Curves were generated for 
the NK cells, at E:T ratios of 25:1 (V), 50:1 
(A), and 100:1 (A). Control cells at 25:1 
( +) or 50:1 ( x ) ratios were incubated for 
various times 
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Figure 14. Treatment of NK cells with antl-Thy 1.2 
monoclonal antibody. NK cells were incubated 
with anti-Thy 1.2 (A) or antl-SRBC ( + ) 
antibodies plus complement at various E:T 
ratios. The cells were washed and then tested 
against Yac-1 tumor cells in a ^'cr release 
assay 
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b. Lvt 1. 2 These experiments were designed to 
determine whether the effector cells were CTLs. Effector 
cells were preincubated with anti-Lyt 2 or anti-Lyt I 
5 1 
monoclonal antibody before use in a Cr Release assay. No 
difference was observed in the cytolytic activity of the 
effector cells whether they were pretreated with anti-Lyt 2 
mAb or anti-Lyt 1 mAb (Figure 15). Thus, the effector 
cells were not CTLs. 
c. Asialo GMl and C These experiments were 
designed to determine whether the effector cells were NK 
cells. The effector cells were pretreated with anti-asialo 
GMj and C before use in a ^'cr release assay. The 
cytolytic activity was inhibited at a dilution of 1:100, 
but returned at higher dilutions (Figure 16). When the 
effector cells were pretreated with the anti-asialo GMj at 
a dilution of 1:10, there was no activity at any E:T ratio 
(Figure 17). Thus, the effector cells were indeed NK 
eel Is. 
4. Effect of conditions required for MELIA on NK activity 
a. The effect of Whitten and Biqgers medium on NK 
activity Because mouse embryos require WB medium to 
grow, a ^'cr release assay was done in WB medium or RPMI+ 
to determine whether NK cells could lyse Yac-1 tumor cells 
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Figure 15. Treatment of NK cells with Lyt 2 or Lyt I 
antibody. NK cells were Incubated with either 
ant I-Lyt 2 ( ^  ) or ant I-Lyt 1 (O) monoclonal 
antibody before use In a ^^Cr release assay 
against Yac-1 tumor cells 
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Figure 16. Titration of antl-aslalo GM. polyclonal 
antibody. NK cells were incubated at various 
dilutions of antl-aslalo GM. (v) or normal 
rabbit serum (^) plus complement. The cells 
were washed and tested against Yac-I tumor 
cells In a ^'cr release assay 
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Figure 17. Treatment of NK cells with antl-aslalo GM. 
polyclonal antibody. NK cells were Incubated 
at various E:T ratios with antl-aslalo GM. 
( V ) or normal rabbit serum (*) plus 
complement. The cells were washed and then 
51 
tested against Yac-I tumor cells In a Cr 
release assay 
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while In WB medium. The results (Figure 18) Indicate that 
the specific lysis of Yac-1 tumor cells was the same 
whether the assay was done in RPMI+ or In WB medium. 
Therefore, the NK cells would be able to function properly 
In the NK MELIA. 
b. The effect of mitomycin c on NK activity A 
^'cr release assay was done to determine whether DNA 
synthesis was required for NK activity against the Yac-1 
tumor cells. Spleen cells from CBA mice were pre-Incubated 
with 100 ug/mL of mitomycin c, which was found to be 
sufficient to inhibit 3H-thymidlne uptake by the spleen 
cells (Figure 19), and washed three times with RPMI+ before 
incubation with ^H-TdR. The results (Figure 20) indicate 
that DNA synthesis was not required for NK activity. 
Therefore, It was decided that the effector cells could be 
pre-Incubated with 100 wg/mL of mitomycin c for one hour, 
washed three times, and then incubated with the embryos 
without masking the embryonic uptake of ^ H-thymidine. 
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Figure 18. The effect of Whitten and BIggers medium on NK 
cell activity. NK cells were tested against 
the Yac-I tumor cells In a ^ ^Cr release assay 
In either WB medium ( *) or RPM1+ (A) 
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Figure 19. Titration of mitomycin c effect on H-TdR 
Incorporation. Spleen cells at 1 x 10^ (©), 2 
X 10^ (O), and 4 x 10^ (#) cells/mL were 
Incubated at various concentrations of 
mitomycin c. The cells were washed and 
3 
Incubated with H-TdR for 4-hours 
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Figure 20. The effect of mitomycin c on NK cell activity. 
NK cells were Incubated for one hour with 
mitomycin c at 100 wg/mL (^) or RPMI+ (A), 
and then washed with RPHI+ and tested against 
Yac-1 tumor cells In a ^ 'cr release assay. 
Spleen cells from A/J mice were used as the 
negative control ( x ) 
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C. Parameters for LAK ^'cr Release Assay 
1. Production of Ivmphoklne activated killer cells 
a. Determination of maximum lL-2 activity The 
optimal concentration of IL-2 to stimulate cell division as 
measured by ^H-TdR incorporation was determined. The 
results (Figure 21) indicate that when LBRM-33A cells were 
stimulated with 20 wg/mL of con A, the resulting IL-2 
caused the maximum uptake of ^ H-TdR at a dilution of 1:16 
and therefore should be used at that concentration. 
b. Activity of LAK cells An experiment was done 
to determine whether culturing spleen cells in IL-2 would 
augment their activity. CBA spleen cells were preincubated 
with IL-2 for three days before use in a ^'cr release 
assay. The results (Figure 22) Indicate that the cultured 
cells had a higher specific lysis of Yac-1 tumor cells than 
fresh CBA or A/J spleen cells. This augmented activity was 
found to be highest at an E:T ratio between 50:1 and 200:1. 
2. Time course for LAK cell lysis of target cells 
The next experiment was done to determine the time 
required for LAK cells to lyse Yac-1 tumor cells in a ^'cr 
release assay. Figure 23 shows the specific lysis of the 
Yac-1 cells at different times and E:T ratios. The results 
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Figure 21. Titration of InterIeukIn-2 (IL-2). Spleen 
cells at 5 X 10^ cells/mL were Incubated for 24 
hours at various concentrations of IL-2 (*) or 
with RPMI+ (X). The cells were Incubated with 
3 
H-TdR for an additional 4 hours and then 
harvested 
74 
30-
.02 20-
O 
1 0 -
2 5 50 100 200 400 
Effector : Target 
Figure 22. Activity of lymphokine activated killer (LAK) 
cells. CBA spleen cells were incubated with 
IL-2 for three days before use as LAK cells. 
Fresh CBA (A) and A/J ( x ) spleen cells and 
LAK cells (O) were used in a ^'cr release 
assay against Yac-I tumor cells 
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Figure 23. Time dependence of LAK cell lysis of Yac-l 
target cells. LAK cells were tested against 
Yac-l tumor cells In a ^^Cr release assay. The 
curves were generated at E:T ratios of 25:1 
( 0 ), 50:1 (0)t and 100:1 (•) at various 
Incubation times 
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Indicate that at each E:T ratio, the killing of Yac-l 
Increased with time and then started to level off at 10 to 
12 hours. Because of these results and the fact that CF-l 
blastocysts Incorporate the maximum amount of 
radioactivity Into their DNA with a 4-hour preincubation 
followed by an 8-hour Incubation In ^H-thymldine (150), a 
12-hour assay period was chosen for the LAK MELIA. 
3. Specificity of LAK cells towards tumor cells 
To test the specificity of LAK cells, an assay was 
done with the Yac-l (H-2^). EL-4 (H-2b). and P815 (H-2^) 
tumor cell lines as target cells. The results Indicate 
that LAK cells have higher activity than fresh spleen cells 
for all three cell lines: Yac-l (Figure 24), EL-4 (Figure 
25), and P815 (Figure 26). Thus, LAK cells showed no 
specificity for either NK sensitive or Insensitive, cells 
or for cells with a particular H-2 haplotype. 
4. Removal of Ivmohokine activated killer cell activity 
with antibody 
a. Thy 1 and C These experiments were designed 
to determine whether the effector cells were T cells. 
Effector cells were prelncubated with anti-Thy 1.2 
monoclonal antibody and complement (C) or anti-SRBC mAb 
and C before use In a ^'cr release assay against Yac-l 
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Figure 24. Activity of lymphokine activated killer (LAK) 
cells against Yac-l cells. CBA spleen cells 
were Incubated with lL-2 for three days before 
use as LAK eel Is. Fresh CBA {A) and A/J ( x ) 
spleen cells and LAK cells (O) were used In a 
51 a 
Cr release assay against Yac-l (H-2 ) tumor 
cells 
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Figure 25. Activity of lymphoklne activated killer (LAK) 
cells against EL-4 cells. CBA spleen cells 
were Incubated with IL-2 for three days before 
use as LAK eel Is. Fresh CBA (A) and A/J ( x ) 
spleen cells and LAK cells (O) were used In a 
^'cr release assay against EL-4 (H-2^) tumor 
cells 
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Figure 26. Activity of lymphoklne activated killer (LAK) 
cells against P815 cells. CBA spleen cells 
were incubated with IL-2 for three days before 
use as LAK eel Is. Fresh CBA ( A) and A/J { x ) 
spleen cells and LAK cells (O) were used in a 
^'cr release assay against P815 (H-2^) tumor 
cells 
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tumor cells. The results (Figure 27) indicate that the 
cytolytic activity was not inhibited at the dilution that 
inhibited CTL activity (1:10, Figures 5 and 6). Thus, the 
effector cells were not T cells. 
b. Lvt 1. 2 These experiments were designed to 
determine whether the effector cells were CTLs. Effector 
cells were preincubated with anti-Lyt 2 or anti-Lyt 1 
monoclonal antibody before use in a ^'cr Release assay. No 
difference was observed in the cytolytic activity of the 
effector cells whether they were pretreated with anti-Lyt 2 
mAb or anti-Lyt 1 mAb (Figure 28). For some unknown 
reason, the activity actually increased for the effector 
cells incubated with anti-Lyt 2. Thus, the effector cells 
were not CTLs. 
c. Asialo GMl and C These experiments were 
designed to determine whether the effector cells were NK 
cells. The effector cells were pretreated with anti-asialo 
GMj and C before use in a ^'cr release assay. When the 
effector cells were pretreated with the anti-asialo GMj at 
a dilution of 1:10, there was no effect on the activity at 
any É:T ratio (Figure 29). Thus, the effector cells were 
not NK cells. 
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Figure 27. Treatment of LAK cells with antl-Thy 1.2 
monoclonal antibody. LAK cells were incubated 
with either RPMI+ (o) or anti-Thy 1.2 (•) 
plus complement at various E:T ratios. The 
cells were washed and tested against Yac-I 
5 1 
tumor cells in a Cr release assay. Fresh CBA 
(A) and A/J ( x ) spleen cells were used as 
control s 
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Figure 28. Treatment of LAK cells with Lyt 2 antibody. 
LAK cells were Incubated with either antl-Lyt 2 
{ © ) or antl-Lyt 1 (®) monoclonal antibody for 
one-hour. A ^'cr release assay was done 
against Yac-1 tumor cells with untreated LAK 
eel Is (O) and A/J (x ) spleen eel Is as 
controls 
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Figure 29. Treatment of LAK cells with antl-aslalo GM. 
polyclonal antibody. LAK cells at several E:T 
ratios were Incubated with either RPHI+ (O) or 
antl-aslalo GM^ (5) plus complement. LAK 
cells were washed and tested against Yac-I 
tumor cells In a ^'cr release assay. Fresh CBA 
(A) and A/J ( x ) spleen eel Is were used as 
control s 
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5. Effect of conditions required for HELIA on LAK activity 
a. The effect of Whitten and Biggers medium on LAK 
actIvitv Because mouse embryos require WB medium to 
grow, a ^*Cr release assay was done In WB medium or RPMI+ 
to see If LAK cells would lyse Yac-1 tumor cells while in 
WB medium. The results (Figure 30) indicate that the 
specific lysis of Yac-1 tumor cells was the same whether 
the assay was done in RPM1+ or In WB medium. Therefore, 
the LAK cells would be able to function properly in the LAK 
MELIA. 
b. The effect of mitomycin c on LAK activity A 
^^Cr release assay was done to determine whether DNA 
synthesis was required for LAK activity against the Yac-1 
tumor cells. LAK cells were pre-incubated with 100 ug/mL 
of mitomycin c, washed three times, and then Incubated for 
four hours with 3H-thymldI ne. The results (Figure 30) 
indicate that DNA synthesis was not required for LAK 
activity. Therefore, it was decided that the effector 
cells could be pre-Incubated with lOOpg/mL of mitomycin c 
for one hour, washed three times, and then incubated with 
the embryos without masking the embryonic uptake of 
^H-thymld i ne. 
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Figure 30. The effect of mitomycin c or Whitten and 
Blggers medium on LAK cell activity. LAK cells 
were Incubated for one hour In either WB medium 
(*) or RPMI+ ( O ) or they were treated with 
mitomycin c at 100 wg/mL ( + ). The cells were 
then tested against Yac-1 tumor cells In a 
release assay with fresh CBA ( a ) and A/J (x ) 
spleen cells as controls 
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D. Manipulation of Embryos 
1. Time course of incorporation of ^ H-TdR by blastocvst-
staqe embryos 
The optimal time period for CF-I blastocysts (93 hours 
post-hCG) to incorporate ^H-TdR has been shown to be eight 
hours (150). However, the data for the inbred strains, 
C57BL/6 (H-2^) and 810.02 (H-2^). needed to be collected 
and are shown in Figure 31. Blastocysts collected 93-
hours post-hCG from the C57BL/6 strain incorporated ^H-TdR 
much better than those from the B10.D2 strain collected at 
the same time. This discrepancy was resolved when the 
B10.D2 embryos were collected at 85 hours post-hCG (Figure 
31). The explanation is that since the B10.D2 embryos 
develop faster than C57BL/6 embryos (152,153), the BIO.02 
embryos collected at 93 hours post-hCG have probably 
undergone the final cell division possible in WB medium. 
Therefore, CF-1, C57BL/6 and 810.02 blastocysts were 
collected 93, 93, and 85 hours post-hCG, respectively, and 
then incubated with ^H-TdR for 4-8 hours. 
2. Correlation of the number of embryos per well to cpm 
per we 11 
Because the number of embryos collected per 
superovu1ated mouse varied from day to day, the number of 
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Figure 31. Kinetics of the Incorporation of H-TdR by 
blastocysts. Embryos were Incubated for 4-
hours In 100 pi of WB medium. After addition 
of 100 yl of 8 yCl/mL ^H-TdR In WB medium, the 
embryos were Incubated for 0-12 hours. The 
embryos were C57BL/6 blastocysts collected 93-
hours post-hCG (•), and B10.D2 blastocysts 
collected at 93-hours (•) or 85-hours (O) 
post-hCG Injection 
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embryos used in an experiment differed. To compensate for 
this, all data were calculated on a per embryo basis. 
Several experiments were performed to determine whether the 
number of embryos per well was proportional to the cpm per 
well. The results (Figure 32) Indicate that the number of 
embryos correlated with the cpm per well (r value = .995). 
Therefore, the assumption that the data could be calculated 
on a per embryo basis was correct. 
3. Effect of removal of zona pel lue I da with Tvrode's acid 
water on ^H-TdR uptake 
Many of the experiments done with embryos required 
that the zonae pellucldae be removed. This procedure could 
be done with pronase; however, the surface antigens on the 
embryos would be stripped off and would require 4-6 hours 
to be resynthesI zed (35). Since the ZP2 protein of the 
zona pelluclda Is sensitive to acidic conditions (23), 
embryos could be treated with Tyrode's acid water (pH 2.5) 
to remove the zonae pellucldae. An experiment was done to 
determine whether this treatment would affect the embryo's 
ability to Incorporate ^H-TdR. The results (Table V) 
Indicate that there was no effect on embryonic uptake of 
^H-TdR after treatment with Tyrode's acid water. 
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Figure 32. Correlation of the number of embryos per well 
to cpms per well. Varying numbers of embryos 
were Incubated for 4-hour3 In 100 w1 of WB 
medium. After addition of 100 w1 of 8 uCI/mL 
3 
H-TdR In WB medium, the embryos were Incubated 
for 8 hours. The number of embryos correlated 
with the cpm per well with an r value of .995 
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Table V. Treatment of embryos with Tyrode's acid water on 
incorporation of H-TdR 
No. of cpm per 
Treatment Embryos Embryo S.D. Significance 
Control 16 312 47 
Tyrode's 11 311 12 N.S.^ 
1. Significance determined by student's t test. 
2. N.S. means not significant. 
4. Effect of Incubation of embryos in 1nterIeuk1n-2 (IL-2) 
on ^H-TdR uptake 
The MELIA measures the effects of cytotoxic immune 
cells on prelmpiantation mouse embryos. An assay was done 
to insure that effect was due to the cytolytic nature of 
the Immune cells and not on the major lymphokine secreted 
by these cells, IL-2. CF-1 embryos were preincubated for 
four hours with IL-2 before incubation with ^H-TdR for 8 
additional hours. The results (Figure 33) Indicate that 
the only concentration that inhibited the activity was 1:2. 
Because the cytotoxic cells were thoroughly washed before 
use, the Inhibition of viability seen in the MELIA can be 
assigned to the cytolytic nature of the immune cells 
1nvolved. 
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Figure 33. Effect of incubation of embryos In IL-2 
(Interleukln-2) on ^H-TdR uptake. Blastocysts 
from CF-1 mice were prelncubated for four-hours 
with IL-2 before incubation with ^H-TdR for 8 
additional hours 
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E. Mixed Embryo Leukocyte Interaction Assay (MELIA) 
1. Effect of CTLs on mouse blastocysts 
a. Effect of CTLs on mouse blastocysts which possess 
their zonae pellucidae In order to lyse their targets, 
CTLs must have direct contact with the target cells (154). 
To determine if the zona pellucida acts to block this 
contact, a MELIA was done comparing the lysis of blastocyst 
stage embryos that either had or did not have their zonae 
pellucidae removed. The cytotoxicity was measured by the 
visual observation of the blastocysts after a four-hour 
incubation with the CTLs. Blastocysts were scored for 
either retention or loss of the blastocoel. The results 
(Table VI) indicate that the zona pellucida blocks the 
deleterious effects of CTLs on embryos. 
b. Effects of CTLs on mouse blastocysts which lack 
their zonae pellucidae 
1) Retention of blastocoel The effect of the 
CTLs at various E;T ratios on mouse embryos which lacked 
their zonae pellucidae was tested two ways. The first 
method was the visual observation of the blastocysts after 
a four-hour incubation with the CTLs. Blastocysts were 
scored for either the retention or loss of the blastocoel. 
The results for C57BL/6 (embryos In Table VII and 
Table VI. The zona pellucfda prevents killing of mouse 
blastocysts by CTLs 
Presence (+) or 
Expt. Absence (-) of 
Number Zona Pelluclda 
Effector 
CTLs 
Target 
Embryos 
E:T 
Rat f o 
No. of 
Embryos 
Tested 
I + Contro1 C57BL/6 100: I 5 
+ antl-H-Z^ C57BL/6 100:1 7 
- Control C57BL/6 100:1 12 
- antf-H-Z^ C57BL/6 100:1 Z1 
11 + Control C57BL/6 50: I 10 
+ anti-H-Z^ C57BL/6 50: 1 1 I 
- Control C57BL/6 50: I IZ 
- anti-H-Z^ C57BL/6 50: 1 13 
Ill + Control BIO.DZ 50: I 6 
+ antl-H-Z^ BIO.DZ 50: I 8 
- Control BIO.DZ 50: I 8 
- anti-H-Z^ BIO.DZ 50: 1 8 
+ Contro1 BIO.DZ 25: 1 8 
+ antl-H-Z^ BIO.DZ 25:1 7 
- Contro1 BIO.DZ 25: 1 7 
- antl-H-Z^ BIO.DZ 25: 1 7 
I. Probability, as determined by Chi square analysis, that 
CTLs cause blastocoel collapse In the absence, but not 
the presence of the zona pelluclda. 
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Percent 
Percent Relative 
Blastocoel Blastocoel 
Retention Retention P 
100  
1 0 0  1 0 0  
1 0 0  
57 57 P < 0.0001 
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1 0 0  1 1 1  
1 0 0  
54 54 P < 0.0001 
88 88 
100 100 
100 100 
63 63 P < 0.0001 
100 100 
100 100 
71 71 
57 57 P < 0.0001 
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Table VII. Effect of antl-H-2 CTLs on blastocoel retention 
by zona-free C57BL/6 (H-2 ) mouse blastocysts 
Expt. E;T 
No. CTLs Ratio 
No. of 
Embryos 
Tested 
No. of 
6lastocoels 
Reta ined 
Percent 
BlastocoeI 
Retention 
Percent 
Re I at i ve 
BIastocoeI 
Retent i on 
Control 400: I 20 16 80 
ant i-H-2^ 400: 1 22 6 27 34 
Control 400: 1 5 5 100 
anti-H-2^ 400: I 5 3 60 60 
Control 100: 1 5 5 100 
anti-H-2b 100: 1 5 4 80 80 
Contro1 50: 1 5 5 100 
anti-H-2^ 50: 1 5 3 60 60 
Control 25: 1 5 5 100 
anti-H-2b 25:1 5 4 80 80 
Control 100: 1 4 4 100 
antl-H-2b 100:1 5 4 80 80 
Control 100:1 38 37 97 
ant;-H-2b 100:1 57 43 75 77 
Control 50:1 6 5 83 
anti-H-2b 50:1 5 3 60 72 
Control 25:1 6 6 100 
anti-H-2b 25; 1 6 4 67 67 
BIO.02 (H-2^) embryos In Table VIII were pooled and graphed 
In Figure 34. The data (Figure 34) indicate that BIO.02 
(H-2*^) blastocysts are more susceptible to blastocoel 
collapse than C57BL/6 (H-2*^^ blastocysts. This may reflect 
the fact that anti-H-2^ CTLs usually have higher activities 
than antl-H-2^ CTLs (see Figures 1 and 2). 
2) Inhibition of ^ H-TdR Incorporation The 
second method of determining the effect of CTLs on mouse 
embryos was the measurement of the ability of CTLs to 
Inhibit the incorporation of ^H-TdR into the ONA of the 
blastocysts. The results for C57BL/6 (H-2*^^ embryos in 
Table IX and BIO.02 (H-2^) embryos in Table X were pooled 
and graphed In Figure 35. Oue to the variability in the 
Incorporation of ^H-TdR, which was noted by Cozad et al. 
(150), the data were calculated as the percent Inhibition 
of control (Inhibition of ^ H-TdR Incorporation (%)). It is 
clear from the data that both C57BL/6 and BIO.02 blastocyst 
were killed by the appropriate CTLs. 
c. Lack of cross reactivity of CTLs with embrvos 
An experiment was performed to determine whether CTLs 
reacted with the proper specificity when directed towards 
embryos. The cytotoxicity was determined by the visual 
observation of the blastocysts after a four-hour Incubation 
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Table VI11. Effect of anti-H-2^ CTLs on blastocoel retention 
by zona-free BIO.02 (H-2 ) mouse blastocysts 
Percent 
No. of No. of Percent Relative 
Expt. E:T Embryos Blastocoets Blastocoel Blastocoel 
No. CTLs Ratio Tested Retained Retention Retention 
1 Control 200: I 1 1 1 1 100 
anti-H-2^ 200: 1 16 5 31 31 
Control 100: 1 10 10 100 
ant1-H-2^ 100: I 18 7 39 39 
11 Control 100:1 9 7 78 
anti-H-2d 100: 1 9 2 22 28 
111 Contro1 
o
 
tn 3 3 100 
ant1-H-2d cn
 
o
 
3 1 33 33 
IV Control 50: I 7 6 86 
anti-H-fd 50: 1 8 4 50 58 
Control 
LO CV
J 
7 6 86 
anti-H-2'^ 25: 1 6 5 83 97 
V Contro1 50: 1 15 10 67 
ant l-H-2'^ 50: 1 15 3 20 30 
Contro1 25:1 15 7 47 
anti-H-2^ 25:1 15 5 33 71 
VI Control 25: 1 5 5 100 
anti-H-2^ 25: 1 5 4 80 80 
VI 1 Control 25:1 5 5 100 
ant i-H-2'^ 25:1 5 5 100 100 
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Figure 34. Effect of CTLs on blastocoel retention. Anti-
H-2^ CTLs were incubated with C57BL/6 (H-2^) 
blastocysts ( • ) and antl-H-2^ CTLs were 
incubated with 810.02 (H-2^) blastocysts (O). 
After four-hours, the percentage of embryos 
that had retained their blastocoels was 
determined 
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Table IX. Effect of ant1-H-2^ CTLs on DMA synthesis by 
zona-free C57BL/6 (H-2 ) mouse blastocysts 
No. of cpm % Inhibition 
Expt Effector E:T Embryos per of H-TdR 
No. CTLs Ratio Tested Embryo Incorporation 
I ControI 400: i 10 249 0 
anti-H-Z^ 400: I 9 53 79 
anti-H-2^ ZOO: 1 9 83 67 
anti-H-Z^ 100: 1 14 61 76 
11 Contro1 400: 1 5 92 0 
anti-H-Z^ 400: 1 5 Z2 76 
anti-H-Z^ 100:1 5 20 78 
anti-H-Z^ 50: 1 5 7 92 
111 Control 50:1 3 112 0 
anti-H-Z^ 50: 1 3 97 13 
IV Contro1 50: 1 6 202 0 
anti-H-Z^ 50:1 5 34 83 
Control 25: 1 6 234 0 
anti-H-Z^ Z5: 1 6 154 34 
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Table X. Effect of antl-H-2^ CTLs on DNA synthesis by 
zona-free BIO.02 (H-2 ) mouse blastocysts 
No. of cpm % Inhibition 
Expt Effector E:T Embryos per of H-TdR 
No. CTLs Ratio Tested Embryo Incorporation 
I Control 50: I 7 14 0 
antl-H-2^ 50:1 7 3 79 
Control 25: I 7 52 0 
antl-H-2^ 25: 1 6 18 65 
11 Control 50:1 15 55 0 
ant l-H-2'^ 
o
 
in 15 8 85 
Control 25: 1 15 99 0 
antl-H-2'^ 25: 1 15 53 46 
1 1 1  Control 25: 1 5 144 0 
antl-H-2'^ 25:1 5 84 42 
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Figure 35. Effect of CTLs on incorporation of H-TdR Into 
blastocyst DNA. Anti-H-2^ CTLs were incubated 
with C57BL/6 (H-2^) blastocysts (•) and antl-
H-2^ CTLs were incubated with B10.D2 (H-2^) 
blastocysts (•). After four-hours, the 
embryos were washed and placed in 100 ul of WB 
medium to which 100 w1 of 8 wCi/mL ^H-TdR In WB 
medium were added. The embryos were harvested 
4-8 hours later, and the Inhibition of ^H-TdR 
Incorporation was determined 
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with the CTLs. Blastocysts were scored for either 
retention or loss of the blastocoel. The results (Table 
XI) demonstrate that antl-H-2^ CTLs react only with C57BL/6 
(H-2^) blastocysts, and antl-H-2^ CTLs react only with 
B10.D2 (H-2^) blastocysts. Thus, the CTLs show proper 
specificity for tumor cells (Figures 3 and 4) and embryos. 
Table XI. Lack of cross reactivity of CTLs on zona-free 
blastocysts 
Effector * 
CTLs 
Target 
Embryos 
No. of 
Embryos 
Tested 
No. of 
Blastocoel 
Reta i ned 
Percent 
Blastocoel 
Retent1 on 
Percent 
Re 1 at i ve 
Blastocoel 
Retention P 
Control C57BL/6 44 42 96 100 
antl-H-2'^ C57BL/6 45 43 96 100 N.S.3 
anti-H-2'^ C57BL/6 57 44 77 81 P < .01 
Control BIO.02 15 15 100 
anti-H-2d B10.D2 20 12 60 60 P < .01 
anti-H-2b 810.02 15 15 100 100 N.S. 
1. The E;T ratio was 100:1. 
2. Chi square analysis was used to test for significance. 
3. N.S. means not significant. 
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2. Effect of NK cells on mouse blastocysts 
The effect of NK cells on murine blastocysts was 
determined by measuring the ability of NK cells to inhibit 
the incorporation of ^H-thymidlne into the DNA of the 
blastocysts. This assay has been used previously to 
measure embryo viability (150,151). 
The results indicate that NK cells Inhibited the 
incorporation of ^H-TdR by the CF-l blastocysts either with 
(Table XII and Figure 36) or without the zonae pellucidae 
present (Table XIII and Figure 37). The Inhibition due to 
the CBA cells showed a steady increase for all E:T ratios. 
However, above 200:1, the inhibition of incorporation by 
the A/J cells started to show a nonspecific Increase 
possibly due to a removal of nutrients. 
This alteration of the viability of blastocysts can be 
seen more clearly when the nonspecific Inhibition of 
Incorporation was eliminated by calculating the results as 
a percent Inhibition of the A/J control (Tables XII and 
XIII, Figure 38). These results clearly show that at E:T 
ratios between 50:1 and 400:1, NK cells are able to Inhibit 
the uptake of thymidine for blastocysts whether the zonae 
pellucidae was present or absent. However, the relative 
inhibition at higher E:T ratios (above 400:1) decreases 
probably due to the removal of nutrients for the 
blastocysts. 
Table XII. Effect of NK cells on mouse blastocysts which 
possess 1 their zonae pellucidae 
MEDIUM A/J 
CONTROL • CONTROL A/J AVERAGE A/J 
% of Total % of Medium 
No. of cpm/ No. of cpm/ Med 1 urn No. of Control 
E:T Embryo Embryo Embryo Embryo Control Embryo Average SEM 
800 12 1227 10 614 50 122 75 1.8 
800 9 933 10 643 69 
800 18 1348 10 778 58 
800 20 701 12 685 98 
800 13 643 8 596 93 
800 16 776 
800 6 307 
400 9 1059 15 1035 98 130 89 0.7 
400 12 1227 10 1082 88 
400 9 933 5 702 75 
400 15 1013 15 869 86 
400 13 643 8 543 84 
400 12 458 7 455 99 
400 23 796 
400 16 776 
400 5 126 
400_ 
_242__ 
200 9 1 059 15 1039 98 175 84 1.1 
200 12 1227 5 1022 83 
200 9 933 10 787 84 
200 15 1013 15 886 88 
200 20 701 13 493 70 
200 6 114 6 220 98 
200 12 1220 12 768 63 
200 8 704 8 789 1 12 
200 23 796 
200 4 267 
200 6 271 
100 9 1059 15 1082 102 175 96 0.4 
100 12 1227 10 n i l  91 
100 9 933 10 939 101 
100 15 1013 15 886 88 
100 20 503 20 509 101 
100 13 643 8 590 92 
100 12 458 7 450 98 
100 23 796 
100 6 293 
100 5 201 
50 9 1059 15 861 81 135 95 0.8 
50 15 1013 15 855 84 
50 18 1348 10 1326 98 
50 20 701 15 728 104 
50 12 458 6 482 105 
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AVERAGE CBA PERCENT OF 
CBA CBA Medium Control A/J Control 
EXPERIMENT % of % of Total Total 
No. of cpm/ Medium A/J No.of No. of 
Embryo Embryo Control Control Embryo Avg. SEM Embryo Avg. SEM 
10 856 70 139 165 72 1.6 106 104 
10 578 62 90 
10 728 54 94 
15 776 1 1 1 1 13 
45 490 63 
4 161 52 
15 919 87 89 204 76 0.8 109 78 
10 1 154 94 107 
5 746 80 106 
15 749 74 86 
45 554 70 
30 540 70 
4 294 233 
4 255 105 
15 935 88 90 
1 0 865 71 85 
10 634 68 81 
15 431 43 49 
20 863 123 175 
7 143 64 65 
12 684 56 89 
8 859 122 109 
45 570 72 
4 141 53 
4 51 19 
15 944 89 87 
10 1094 89 98 
10 664 71 71 
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Figure 36. Effect of NK cells on incorporation of H-TdR 
into normal blastocysts. Spleen cells from CBA 
(A) and A/J (x) mice were incubated with CF-1 
blastocysts which possessed their zonae 
pellucidae. After four-hours, the embryos were 
washed and placed in 100 ul of WB medium to 
which was added 100 yl of 8 pCi/mL ^H-TdR in WB 
medium. The embryos were harvested 4-8 hours 
later, and the inhibition of ^H-TdR 
incorporation was determined 
Table XIII. Effect of NK cells on mouse blastocysts which 
lack their zonae pellucidae 
MEDIUM A/J 
CONTROL CONTROL A/J AVERAGE A/J 
% of Total % of Medium 
No. of cpm/ No. of cpm/ Medium No. of Control 
E:T Embryo Embryo Embryo Embryo Contro1 Embryo Average SEM 
800 12 1278 10 709 56 54 66 2.7 
800 5 307 4 342 1 1 1 
800 8 280 8 156 56 
800 2 606 5 399 66 
800 5 275 
400 12 1278 10 694 54 73 62 1.6 
400 8 280 6 138 49 
400 12 606 14 469 77 
400 6 170 
400 5 207 
200 12 1278 10 1 116 87 73 98 1.6 
200 8 821 7 892 109 
200 8 469 12 432 92 
200 8 704 8 789 112 
200 5 270 
200 5 201 
100 12 1278 10 1 176 92 66 82 0.9 
100 8 600 12 476 79 
100 12 634 12 484 76 
100 5 144 
50 12 1278 10 1 196 94 22 94 
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AVERAGE CBA PERCENT OF 
CBA CBA Med 1 urn Contro1 A/J Control 
EXPERIMENT % of % of Tota 1 Tota 1 
No. of cpm/ Medium A/J No.of No. of 
Embryo Embryo Contro1 Control Embryo Avg. SEM Embryo Avg. SEM 
10 676 53 95 22 53 29 83 3.4 
4 151 55 
10 800 63 1 15 22 63 41 94 3.6 
6 102 60 
4 198 95 
10 1011 79 91 78 66 2.1 110 71 1 . 1 
8 266 33 30 
12 373 79 86 
8 615 67 71 
5 209 77 
4 100 50 
10 957 75 81 66 64 1.4 76 77 1 . 1 
12 425 71 89 
12 313 49 77 
3 101 70 
10 975 76 81 22 76 22 81 
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Figure 37. Effect of NK cells on incorporation of H-TdR 
into zona free blastocysts. Spleen cells from 
CBA (A) and A/J (x) mice were incubated with 
CF-1 blastocysts which lacked their zonae 
pellucidae. After another four-hours, the 
embryos were washed and placed in 100 w1 of WB 
medium to which was added 100 pi of 8 yCi/mL 
3 
H-TdR In WB medium. The embryos were 
harvested 4-8 hours later, and the inhibition 
of ^H-TdR incorporation was determined 
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35-1 
Figure 38. Actual effect of NK cells on blastocysts. The 
nonspecific inhibition of ^H-TdR incorporation 
was eliminated by calculating the inhibition of 
^H-TdR incorporation due to NK cells as a 
percentage of the A/J inhibition. The effects 
of the NK cells on blastocysts which possess 
(A) and lack (A) their zonae pellucidae are 
shown 
I l l  
3. Effect of LAK cells on mouse blastocysts 
The effect of LAK cells on murine blastocysts was 
determined by measuring the ability of LAK cells to 
Inhibit the Incorporation of ^ H-thymldlne Into the DNA of 
the blastocysts. This assay has been used previously to 
measure embryo viability (150,151). 
The results indicated that LAK cells Inhibit the 
incorporation of ^H-TdR by CF-1 blastocysts either with the 
zonae pellucidae present or absent (Table XIV). These 
results are shown in Figures 39 (zona pellucida present) 
and Figure 40 (zona pellucida absent). These figures show 
that LAK cells altered the viability of the blastocysts to 
a greater degree than cells from A/J mice. 
This alteration of the viability of blastocysts can be 
seen more clearly when the nonspecific inhibition of 
incorporation was eliminated by calculating the results as 
a percent inhibition of the A/J control (Table XIV, Figure 
41). These results clearly show that LAK cells inhibit, on 
an equal basis, the embryonic uptake of thymidine whether 
or not the zonae pellucidae was present. 
Table XIV. Effect of LAK cells on mouse blastocysts 
MEDIUM A/J 
CONTROL CONTROL A/J AVERAGE A/J 
E:T 
No. of 
Embryo 
cpm/ 
Embryo 
No. of 
Embryo 
cpm/ 
Embryo 
% of 
Medium 
Control 
Tota 1 
No. of 
Embryo 
% of Medium 
Control 
Average SEM 
Zona pellucida present 
200 12 1220 12 768 63 48 83 3.8 
200 8 704 8 789 1 12 
100 20 503 20 509 101 40 101 
Zona pellucidae absent 
200 8 469 8 432 92 32 94 0.2 
200 8 919 8 872 95 
100 8 600 8 477 80 38 78 0.2 
100 12 634 10 484 76 
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AVERAGE LAK PERCENT OF 
LAK LAK Medium Control A/J Control 
EXPERIMENT % of % of Total Total 
No. of cpm/ Medium A/J No.of No. of 
Embryo Embryo Control Control Embryo Avg. SEM Embryo Avg. SEM 
12 716 93 59 49 60 0.2 49 74 2.7 
17 433 55 62 
20 371 73 74 40 74 40 73 
8 388 90 83 41 67 1.9 41 72 2.2 
8 528 61 58 
8 345 72 58 40 56 0.2 38 72 0.0 
12 351 72 55 
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Figure 39. Effect of LAK cells on Incorporation of H-TdR 
Into normal blastocysts. LAK cells (O) and 
spleen cells from A/J (x) mice were Incubated 
with CF-1 blastocysts which possess their zonae 
pellucldae. After four-hours, the embryos were 
washed and placed In 100 wI of WB medium to 
which was added 100 iil of 8 wCI/mL ^H-TdR In WB 
medium. The embryos were harvested 4-8 hours 
later, and the Inhibition of viability was 
determined 
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Figure 40. Effect of LAK cells on Incorporation of ^H-TdR 
Into zona free blastocysts. LAK cells (•) and 
spleen cells from A/J ( x) mice were Incubated 
with CF-1 blastocysts which lack their zonae 
pellucldae. After four-hours, the embryos were 
washed and placed In 100 wl of WB medium to 
which was added 100 wI of 8 wCI/mL ^H-TdR In WB 
medium. The embryos were harvested 4-8 hours 
later, and the inhibition of viability was 
determined 
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Figure 41. Actual effect of LAK cells on Blastocysts. The 
nonspecific inhibition of ^H-TdR incorporation 
was eliminated by calculating the inhibition of 
viability due to LAK cells as a percentage of 
A/J inhibition. The effects of the LAK cells 
on blastocysts which possess (O) and lack (•) 
their zonae pellucidae are shown 
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V. DISCUSSION 
A specific or nonspecific cellular immune rejection 
may account for the 30-77% of all conceptuses which are 
lost by the first post-fertilization menstrual period (52). 
Some of the Immune cells that may be responsible for this 
rejection are the CTLs, NK cells, or LAK cells. 
Preimplantatlon mouse embryos have been shown to 
express H-2 antigens on their surfaces (30-35). CTLs are T 
cells that recognize target antigens In association with 
MHC antigens (or allogeneic MHC antigen alone) and then 
lyse those cells that harbor the target molecules (14). 
NK cells are large granular lymphocytes that kill 
certain target cells without prior sensitization or without 
MHC restriction (82). Nondifferentlated embryonal 
carcinoma cells, which share surface characteristics with 
preimplantatlon embryos (155), are susceptible to lysis by 
NK cells (91). It is therefore logical to test whether NK 
cells can kill mouse embryos at the preimplantatlon stage 
of development. 
Lymphokine activated killer (LAK) cells are artificial 
Immune cells that have been activated by high levels of the 
lymphokine lnterleukin-2 (82,83,84,85). LAK cells can lyse 
cultured tumor cells that are either NK susceptible or NK 
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resistant (86,87). LAK cells can also lyse fresh tumor 
cells, which very few cytotoxic cells can do (88,89). 
A summary of the phenotype and cytolytic properties of 
the cytotoxic Immune cells used for these studies are 
presented In Table XIV. 
Table XIV. Characteristics of the cytotoxic T lymphocytes 
(CTLs), natural killer (NK), and lymphoklne 
activated killer (LAK) cells 
Characteristic CTLs NK cells LAK cells 
Time used for 
spec If i c lysis 
(hours) 4 12 12 
H-2 restriction + - -
Restriction to 
NK-sensitive cells - + -
Thy 1.2 + 
Lyt 1 - - -
Lyt 2 + - -
Aslalo GMj - + -
Active In WB Medium + + + 
Active after 
mitomycin c 
treatment not determined + + 
The immune cells' phenotypes were as expected based on 
data from other laboratories (55-58,84,103). The LAK 
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cells' phenotype indicated that they were in the early 
stages of differentiation, as expected for a three day 
culture. 
To determine whether CTLs will kill cells of 
preimplantation embryos, a series of experiments were 
performed in which blastocyst embryos were incubated with 
CTLs. The CTLs used for the experiments were produced by 
cross-stimulation with cells from mice that were congenic 
at the H-2 complex and therefore should only recognize H-2 
molecules as their target structures. The data shown in 
Figures 3,4 and Table XI demonstrate that the CTLs were 
indeed specific for the proper H-2 molecules on tumor and 
embryonic eel 1 s. 
CTLs caused the collapse of the blastocoel (Tables VII 
and VIII, Figure 34). These results indicate that the H-2 
antigens present on the surface of mouse blastocysts are 
recognized by CTLs. CTLs killed the cells of zona-free 
blastocysts, as determined by the inhibition of the 
blastocysts' ability to Incorporate 3H-TdR, by up to 60% 
(Tables IX and X and Figure 35). 
To determine whether NK cells will kill cells of 
preimplantation embryos, a series of experiments were 
performed in which blastocyst embryos were incubated with 
NK cells. Embryos from the CF-I outbred mouse strain were 
used because NK cells kill target cells without MHC 
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restriction (81,84,92,116,118), and CF-1 mice give a higher 
number of embryos per mouse. Spleen cells from CBA mice 
were designated as NK cells, while spleen cells from A/J 
mice served as the negative control (Figure 12). The 
optimal effector to target ratio was found to be between 
50:1 and 400:1, with higher levels of effector cells 
actually inhibiting lysis of the target cells. This 
Inhibition of lysis may be due to steric hindrance, removal 
of the nutrients, and/or removal of the Ca+2 ions, which 
are required for the NK programming for lysis (114-
116,118). At E:T ratios between 50:1 and 400:1, spleen 
cells from strains with high NK activity, but not from 
those with low activity, inhibited zona-free blastocysts' 
ability to incorporate ^H-TdR by up to 50% (Table XIII and 
Figures 37 and 38). Above the E:T ratio of 400:1, spleen 
cells from the low responder strain started to show a 
nonspecific Inhibition of Sy-TdR Incorporation probably due 
to a removal of nutrients. 
To determine whether LAK cells will kill cells of 
prelmplantatIon embryos, a series of experiments were 
performed In which blastocyst embryos were Incubated with 
LAK cells. The LAK cells used for the experiments were 
produced by incubating CBA cells in lL-2 for three days. 
The data shown In Figures 21, 22, 23, and 24 demonstrate 
that the LAK cells were able to lyse all the tumor cells 
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tested. LAK cells killed the cells of zona-free 
blastocysts, as determined by the inhibition of the 
blastocysts' ability to incorporate 3H-TdR, by up to 60% 
(Table XIV and Figures 40 and 41). 
The failure of the immune cells to Iyse all of the 
embryonic cells is probably due to the cellular 
configuration of the blastocyst. The cells of the 
trophoblast may function to prevent lysis of the inner cell 
mass (ICM) by acting as a buffer zone. Since the I CM 
comprises approximately 50% of the embryo's cells, the 
immune cells would not be expected to lyse all of the 
bIastocyst's cells. 
To determine what protects the embryo from destruction 
by the maternal system, a series of experiments were 
performed to determine whether the zona pellucida may serve 
this role. CTLs will only kill the embryo's cells when the 
zona pellucida has been removed (Table VI). The zona 
pellucida provides little or no protection from the 
cytolytic effects of NK cells (Table XII and Figures 36 and 
38) and LAK cells (Table XIV and Figures 39 and 41). 
The differences in the immune cells ability to lyse 
the embryonic cells probably result from the differences 
between which target molecules are recognized by CTLs and 
NK cells. The CTLs bind to the target antigens only in 
conjunction with MHC molecules (14), which are present only 
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on the cellular surface of the embryo (33). In the 
presence of the zona pellucida, CTLs can not bind to the 
target antigens and therefore do not recognize the embryo 
as a target cell. The NK cells' target molecules are the 
carbohydrate moieties found on glycoproteins (93) which can 
be found as part of the zona pellucida (22-28). NK cells 
bind their target antigens and then secrete NK cytotoxic 
factors (NKCF) (95,98), which may cross the zona pellucida 
to lyse the trophoblastic cells. 
Recently, Croy et. aj_. (156) found that spleen cells 
and NK-like cells from the decidua would not kill 
blastocyst- stage embryos. Two reasons may explain the 
discrepancy between their findings and the results shown in 
Tables XII and XIII and Figures 36, 37, and 38. First, 
their NK cells were used at effector to target ratios of 
1000:1 to 3000:1, which may lead to non-specific effects 
(see Figures 12,36,37). Secondly, the blastocysts were 
incubated with the NK cells for only 4-6 hours, which does 
not allow for full activity of the NK cells (Figure 13). 
A complete overview of the results described in this 
thesis, on the effects of the cytotoxic immune cells on 
preimplantation-stage embryos, is presented in Table XV. 
The results reported show that preimplantation mouse 
embryos at the blastocyst-stage of development which lack 
their zonae pellucidae are susceptible to lysis by CTLs, 
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natural killer cells, and lymphoklne activated killer 
cells. The ImmunoprotectIve role that the zona pellucida 
plays in protecting the blastocyst from cytotoxic T 
lymphocytes is only partially effective against NK cells 
and completely ineffective against LAK cells. The 
trophoblastic cells of the blastocyst may play a role in 
protecting the inner cell mass (ICM), from cytotoxic immune 
e e l  I s .  
Table XV. Effects of the cytotoxic T lymphocytes 
(CTLs), natural killer (NK), and lymphoklne 
activated killer (LAK) cells on preimplantation 
mouse embryos 
Effects on Embryos CTLs NK cells LAK cells 
Presence of zona pellucida 
Inhibition of 
Blastocoel 
Retention - N.D. N.D. 
Inhibition of 
"H-TdR 
Incorporation - +++ ++++ 
Absence of zona pellucida 
Inhibition of 
Blastocoel 
Retention ++++ N.D. N.D. 
Inhibition of 
^H-TdR 
Incorporation +++ ++++ ++++ 
1. N.D., not determined. 
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VI. FURTHER EXPERIMENTS FOR PROJECT 
The determination of the effect of cytotoxic Immune cells 
on prelmplantatIon mouse embryos has Just begun. There are 
many additional experiments that could be done. 
The first experiments that could be done deal with the 
replacement of the ^'cr release (157). A flow cytometric 
assay using the Epics flow cytometer would eliminate the use 
of radioactive compounds. By first Incubating the target 
cells with a fluorescent marker, the increase or decrease in 
fluorescence (depending on which marker is used) would 
Indicate the percentage of cells lysed. 
Attempts should be made to clone the CTLs. Previous 
attempts failed to achieve clones probably due to inadequate 
supplies of IL-2 (158). The initial attempts used IL-2 
produced from rat and mouse spleen cells, which did not 
produce large quantities. Through the use of the LBRM-33A 
and EL-4.IL-2 cell lines, large quantities of the lymphokine 
could be obtained. 
Further HELIAs should be done with all effector cells. 
There should be a time course done with the embryos to 
determine whether a higher lysis of the embryonic cells can 
be achieved. Earlier stages of embryonic development might 
decrease the reactivity of the CTLs due to lower H-2 
concentration, but might increase the reactivity of LAK and 
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NK cells due to the less differentiated state of the cells. 
Experiments to determine whether the Inner cell mass Is 
susceptible to lysis would be Interesting. HELIAs with LAK 
cells and NK cells should include embryos from the strains 
used with the CTLs. 
Experiments should be done to determine the presence of 
Qa-2 antigens, which are Important in the control of the rate 
of preimplantatIon embryo development (3,4), on the embryos. 
CTLs could be produced with the congenic lines that differ at 
the Qa-2 loci: B6.K1 and B6.K2, BALB/cJ and BALB/cBy. The 
MELIA would then determine whether Qa-2 antigens on the 
embryos could be recognized by antl-Qa-2 CTLs. 
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